{"span_id": "def190ba64ed7205", "trace_id": "890f6add8b0548116b8e4ddd42712a8e", "parent_id": null, "name": "tool.categorization.gamp_analysis", "kind": "INTERNAL", "start_time": 1755776015416232600, "end_time": 1755776015416651600, "duration_ns": 419000, "status": {"status_code": "OK", "description": null}, "attributes": {"tool.name": "gamp_analysis", "tool.category": "categorization", "tool.type": "pharmaceutical_agent_tool", "tool.function": "gamp_analysis_tool", "compliance.gamp5.category": "tool_execution", "compliance.audit.required": true, "compliance.pharmaceutical.tool": true, "tool.critical": true, "tool.regulatory_impact": true, "tool.input.arg_count": 1, "tool.input.kwarg_count": 0, "tool.input.arg_types": "['str']", "tool.execution.duration_ms": 0.31280517578125, "tool.execution.status": "success", "tool.output.type": "dict", "tool.output.dict_keys": "('predicted_category', 'evidence', 'all_categories_analysis', 'decision_rationale', 'summary')"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:35.416728", "span_type": "tool", "tool_name": "gamp_analysis", "tool_category": "categorization"}
{"span_id": "d22d8a5174aa44bb", "trace_id": "82b79aeff0ed8b3e028596f880e5159b", "parent_id": null, "name": "tool.categorization.confidence_scoring", "kind": "INTERNAL", "start_time": 1755776015417498200, "end_time": 1755776015417565700, "duration_ns": 67500, "status": {"status_code": "OK", "description": null}, "attributes": {"tool.name": "confidence_scoring", "tool.category": "categorization", "tool.type": "pharmaceutical_agent_tool", "tool.function": "confidence_tool", "compliance.gamp5.category": "tool_execution", "compliance.audit.required": true, "compliance.pharmaceutical.tool": true, "tool.critical": true, "tool.compliance_required": true, "tool.input.arg_count": 1, "tool.input.kwarg_count": 0, "tool.input.arg_types": "['dict']", "tool.execution.duration_ms": 0.010967254638671875, "tool.execution.status": "success", "tool.output.type": "float"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:35.417608", "span_type": "tool", "tool_name": "confidence_scoring", "tool_category": "categorization"}
{"span_id": "c72343257d190921", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.query", "kind": "INTERNAL", "start_time": 1755776018018892100, "end_time": 1755776018055249200, "duration_ns": 36357100, "status": {"status_code": "UNSET", "description": null}, "attributes": {"vector_db.operation": "query", "compliance.gamp5.vector_operation": true, "compliance.pharmaceutical": true, "data_integrity.vector_search": true, "chromadb.query.n_results": 10, "chromadb.query.status": "success", "chromadb.query.result_count": 10, "chromadb.query.avg_distance": 0.8034217417240143}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.055366", "span_type": "vector_database", "database_type": "chromadb", "operation": "query", "result_count": 10, "avg_distance": 0.8034217417240143}
{"span_id": "4c8f4f21716b9524", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.chunk.1", "kind": "INTERNAL", "start_time": 1755776018060890700, "end_time": 1755776018060957400, "duration_ns": 66700, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 1, "chunk.node_id": "3bd1baa0-935f-4ffb-8ecf-1bf60006f499", "chunk.score": 0.48970473038442924, "chunk.title": "Untitled Document", "chunk.type": "testing_methodology", "chunk.text_length": 357, "chunk.has_embedding": false, "chunk.metadata.file_name": "test_urs.txt", "chunk.metadata.file_path": "tests\\test_data\\test_urs.txt", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.687328+00:00", "chunk.metadata.type": "testing_methodology", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "5", "chunk.metadata.test_types": "performance_testing,security_testing,validation_testing", "chunk.metadata.sections": "1. User authentication required,2. Data integrity (ALCOA+ compliance),3. Audit trail logging,4. Electronic signatures", "chunk.metadata.document_title": "Here\u2019s a refined and comprehensive title that incorporates all critical elements while maintaining clarity and conciseness:  \n\n**\"Validation and Testing of a High-Risk Custom Pharmaceutical System: Ensuring ALCOA+ Compliance, Secure User Authentication, Audit Trails, and Electronic Signatures through Rigorous Functional, Performance, and Security Testing (GAMP Category 5)\"**  \n\n### Key Improvements:  \n1. **Structure** \u2013 Opens with the scope (*Validation and Testing*) and system type (*High-Risk Custom Pharmaceutical System*).  \n2. **Compliance Focus** \u2013 Explicitly highlights *ALCOA+* as the core framework.  \n3. **Functional Requirements** \u2013 Bundles *User Authentication, Audit Trails, and Electronic Signatures* as critical features.  \n4. **Testing Rigor** \u2013 Emphasizes *Functional, Performance, and Security Testing* as validation pillars.  \n5. **Regulatory Context** \u2013 Closes with *(GAMP Category 5)* to anchor the high-risk classification.  \n\nThis version balances technical precision with readability, ensuring alignment with regulatory expectations (e.g., FDA 21 CFR Part 11, EU Annex 11) while targeting stakeholders in validation, IT, and quality assurance.  \n\nWould you like further adjustments to emphasize specific aspects (e.g., risk management, scalability)?", "chunk.metadata.excerpt_keywords": "Validation, ALCOA+, User Authentication, Audit Trails, Electronic Signatures, GAMP Category 5, Performance Testing, Security Testing, Pharmaceutical System, Regulatory Compliance"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.061028", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "74c1a017f21baaba", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.chunk.2", "kind": "INTERNAL", "start_time": 1755776018062181300, "end_time": 1755776018062235900, "duration_ns": 54600, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 2, "chunk.node_id": "81aefa78-eb80-409b-88be-8c75d6858ce0", "chunk.score": 0.4769541150233713, "chunk.title": "Untitled Document", "chunk.type": "testing_methodology", "chunk.text_length": 469, "chunk.has_embedding": false, "chunk.metadata.file_name": "test_urs_hitl.txt", "chunk.metadata.file_path": "tests\\test_data\\test_urs_hitl.txt", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.689228+00:00", "chunk.metadata.type": "testing_methodology", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "5", "chunk.metadata.test_types": "performance_testing,security_testing,validation_testing", "chunk.metadata.sections": "1. User authentication required,2. Data integrity (ALCOA+ compliance),3. Audit trail logging,4. Electronic signatures", "chunk.metadata.document_title": "**\"High-Risk Custom Pharmaceutical System: Ensuring GAMP 5 Compliance with ALCOA+ Data Integrity, Robust User Authentication, Comprehensive Audit Trails, Secure Electronic Signatures, and Full-Scale Validation, Performance, and Security Testing\"**  \n\nThis comprehensive title encapsulates:  \n- **Risk Level (High)**  \n- **GAMP Category (5 - Custom Application)**  \n- **Key Functional Requirements** (ALCOA+ Data Integrity, User Authentication, Audit Trails, Electronic Signatures)  \n- **Testing Requirements** (Validation, Performance, Security Testing)  \n- **HITL (Human-in-the-Loop) Test Trigger** for scenario-based evaluation.  \n\nThe title is designed to provide clarity and precision for stakeholders in pharmaceutical compliance, software validation, and regulatory adherence.", "chunk.metadata.excerpt_keywords": "GAMP 5, ALCOA+, pharmaceutical compliance, custom application, high-risk system, user authentication, audit trail, electronic signatures, validation testing, security testing"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.062273", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "2f0d5c799226cf2c", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.chunk.3", "kind": "INTERNAL", "start_time": 1755776018062858400, "end_time": 1755776018062906300, "duration_ns": 47900, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 3, "chunk.node_id": "5b70b237-3851-43d3-942f-604651381597", "chunk.score": 0.45425468888261966, "chunk.title": "Untitled Document", "chunk.type": "testing_methodology", "chunk.text_length": 4009, "chunk.has_embedding": false, "chunk.metadata.file_name": "test_pharmaceutical_urs.txt", "chunk.metadata.file_path": "tests\\test_data\\test_pharmaceutical_urs.txt", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.685423+00:00", "chunk.metadata.type": "testing_methodology", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "4,5", "chunk.metadata.test_types": "performance_testing", "chunk.metadata.sections": "1. Sample Management and Chain of Custody,2. Test Method Management,3. Quality Control and Release,4. Regulatory Compliance Features,5. Integration Requirements", "chunk.metadata.document_title": "A comprehensive and precise title for your document could be:  \n\n**\"Comprehensive User Requirements Specification (URS) for a Customized Laboratory Information Management System (LIMS) in FDA-Regulated Pharmaceutical Manufacturing: Ensuring Compliance with 21 CFR Part 11, ALCOA+ Principles, and GAMP 5 Guidelines\"**  \n\nThis title effectively captures:  \n- The document type (**User Requirements Specification - URS**)  \n- The system in focus (**Customized LIMS**)  \n- The industry context (**FDA-regulated pharmaceutical manufacturing**)  \n- Key compliance frameworks (**21 CFR Part 11, ALCOA+, GAMP 5**)  \n\nIf you prefer a slightly more concise version while retaining all critical elements, you could use:  \n\n**\"User Requirements Specification (URS) for a Pharmaceutical LIMS: Compliance with 21 CFR Part 11, ALCOA+, and GAMP 5 in FDA-Regulated Manufacturing\"**  \n\nBoth options ensure regulatory and technical clarity while maintaining readability. Let me know if you'd like further refinements!", "chunk.metadata.excerpt_keywords": "Keywords: LIMS, Pharmaceutical Validation, 21 CFR Part 11, GAMP-5, ALCOA+, FDA Compliance, Electronic Records, Data Integrity, Sample Management, Quality Control"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.062938", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "ed61851d397a28b0", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.chunk.4", "kind": "INTERNAL", "start_time": 1755776018063382300, "end_time": 1755776018063427600, "duration_ns": 45300, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 4, "chunk.node_id": "25774d54-c90c-4c9b-ab00-ebba95074b65", "chunk.score": 0.44686272018628603, "chunk.title": "Untitled Document", "chunk.type": "regulatory_guidance", "chunk.text_length": 5726, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.650626+00:00", "chunk.metadata.type": "regulatory_guidance", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\"**  \n\nThis title effectively combines:  \n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \n\n*Alternative Concise Version*:  \n**\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\"**  \n\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.", "chunk.metadata.excerpt_keywords": "Here are 10 unique keywords for this document, formatted as comma-separated:  \n\n**Keywords**: GAMP validation, OQ test scripts, pharmaceutical compliance, 21 CFR Part 11, ALCOA+, risk-based testing, computerized systems, PID algorithm, performance testing, electronic batch records"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.063455", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "23d087e24529fcba", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.chunk.5", "kind": "INTERNAL", "start_time": 1755776018063873100, "end_time": 1755776018063918400, "duration_ns": 45300, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 5, "chunk.node_id": "0f4371af-dc06-4b2a-85ae-3dd6f2e3f392", "chunk.score": 0.4459338823697484, "chunk.title": "Untitled Document", "chunk.type": "regulatory_guidance", "chunk.text_length": 5573, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.650626+00:00", "chunk.metadata.type": "regulatory_guidance", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\"**  \n\nThis title effectively combines:  \n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \n\n*Alternative Concise Version*:  \n**\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\"**  \n\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.", "chunk.metadata.excerpt_keywords": "GAMP 5, 21 CFR Part 11, OQ Test Scripts, Pharmaceutical Validation, Risk-Based Testing, ALCOA+, Computer Software Assurance, Electronic Signatures, Audit Trail, Data Integrity"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.063946", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "489ee9887ff2dff6", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.chunk.6", "kind": "INTERNAL", "start_time": 1755776018064412300, "end_time": 1755776018064457800, "duration_ns": 45500, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 6, "chunk.node_id": "c861432b-4379-4525-9bfb-e7b99e4db37b", "chunk.score": 0.4380896854247896, "chunk.title": "Untitled Document", "chunk.type": "regulatory_guidance", "chunk.text_length": 2833, "chunk.has_embedding": false, "chunk.metadata.file_name": "validation_data.md", "chunk.metadata.file_path": "tests\\test_data\\gamp5_test_data\\validation_data.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.691302+00:00", "chunk.metadata.type": "regulatory_guidance", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "", "chunk.metadata.test_types": "", "chunk.metadata.sections": "GAMP-5 Categorization - Validation Data,URS-V01: Manufacturing Execution System (MES),1. Introduction,2. Functional Requirements,3. Regulatory Requirements", "chunk.metadata.document_title": "**Comprehensive Guide to GAMP-5 Categorization, Validation, and Regulatory Compliance for GxP-Compliant Systems: EDMS, CTMS, PLC-Based Autoclave Controller, and Custom Encryption in Manufacturing, Chromatography, Clinical Trials, and Document Management**  \n\nThis title comprehensively captures the scope of the document, including:  \n- **GAMP-5 Categorization and Validation Requirements** for both custom and commercial systems.  \n- **Key GxP-Compliant Systems**: Electronic Document Management System (EDMS), Clinical Trial Management System (CTMS), and PLC-Based Autoclave Controller.  \n- **Custom Encryption (URS-CTMS-013)** for specific jurisdictional needs.  \n- **Regulatory Compliance** with standards such as 21 CFR Part 11, audit trails, and user access controls.  \n- **Functional and System Requirements** for integration, workflows, and process control across manufacturing, chromatography, clinical trials, and document management.", "chunk.metadata.excerpt_keywords": "GAMP-5, validation, regulatory compliance, GxP, EDMS, CTMS, autoclave controller, 21 CFR Part 11, encryption, PLC"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.064484", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "42172c4e73d38337", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.chunk.7", "kind": "INTERNAL", "start_time": 1755776018064856700, "end_time": 1755776018064904400, "duration_ns": 47700, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 7, "chunk.node_id": "855933ad-883d-4ecd-baf8-b34d2ce56d94", "chunk.score": 0.4332589203651332, "chunk.title": "Untitled Document", "chunk.type": "regulatory_guidance", "chunk.text_length": 6776, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.650626+00:00", "chunk.metadata.type": "regulatory_guidance", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\"**  \n\nThis title effectively combines:  \n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \n\n*Alternative Concise Version*:  \n**\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\"**  \n\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.", "chunk.metadata.excerpt_keywords": "GAMP validation, OQ test scripts, pharmaceutical systems, 21 CFR Part 11, ALCOA+, computerized systems, risk-based testing, LIMS validation, GAMP categories, regulatory compliance"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.064930", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "37a171080448c79d", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.chunk.8", "kind": "INTERNAL", "start_time": 1755776018065296600, "end_time": 1755776018065340500, "duration_ns": 43900, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 8, "chunk.node_id": "b5003a9b-e944-419b-ab9f-db545db87a10", "chunk.score": 0.4328670082303556, "chunk.title": "Untitled Document", "chunk.type": "testing_methodology", "chunk.text_length": 2277, "chunk.has_embedding": false, "chunk.metadata.file_name": "test_urs_comprehensive.txt", "chunk.metadata.file_path": "tests\\test_data\\test_urs_comprehensive.txt", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.687328+00:00", "chunk.metadata.type": "testing_methodology", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "5", "chunk.metadata.test_types": "acceptance_testing,regression_testing", "chunk.metadata.sections": "1. USER AUTHENTICATION & ACCESS CONTROL,2. DATA INTEGRITY (ALCOA+ COMPLIANCE),3. ELECTRONIC SIGNATURES,4. AUDIT TRAIL SYSTEM,5. DATA BACKUP & RECOVERY", "chunk.metadata.document_title": "**\"Comprehensive Validation and Compliance Framework for a High-Risk Clinical Data Management System (CDMS): Ensuring ALCOA+ Data Integrity, 21 CFR Part 11 Compliance, GAMP 5 Standards, and Robust Security Protocols in Accordance with ISO 27001, HIPAA, and ICH E6 Guidelines\"**  \n\nThis title comprehensively encapsulates:  \n- **System Type**: Clinical Data Management System (CDMS)  \n- **Risk Level**: High-risk, GxP-impactful  \n- **Key Standards**: ALCOA+, 21 CFR Part 11, GAMP 5, ISO 27001, HIPAA, ICH E6  \n- **Core Themes**: Data integrity, electronic signatures, audit trails, security (encryption, MFA), validation (IQ/OQ/PQ), and performance metrics.  \n- **Unique Entities**: Multi-factor authentication, RBAC, audit trail immutability, backup/recovery (RTO/RPO), and compliance frameworks.  \n\nThe title emphasizes the system\u2019s regulatory rigor, risk management, and end-to-end operational requirements, ensuring clarity and alignment with industry standards.", "chunk.metadata.excerpt_keywords": "Here are 10 unique keywords for this document, formatted as comma-separated:  \n\n**Keywords**: Clinical Data Management System, ALCOA+ Compliance, 21 CFR Part 11, GAMP 5, Electronic Signatures, Audit Trail Immutability, Data Integrity, ISO 27001, HIPAA, Risk-Based Validation"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.065367", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "28de9487b7ea2164", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.chunk.9", "kind": "INTERNAL", "start_time": 1755776018065733100, "end_time": 1755776018065776400, "duration_ns": 43300, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 9, "chunk.node_id": "fc56c7a3-26b3-4aa1-a873-bc51e871fc3d", "chunk.score": 0.43211128995928877, "chunk.title": "Untitled Document", "chunk.type": "regulatory_guidance", "chunk.text_length": 6821, "chunk.has_embedding": false, "chunk.metadata.file_name": "ISPE - GAMP 5_ A Risk-Based Approach to Compliant GxP Computerized_short.md", "chunk.metadata.file_path": "tests\\test_data\\ISPE - GAMP 5_ A Risk-Based Approach to Compliant GxP Computerized_short.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.624352+00:00", "chunk.metadata.type": "regulatory_guidance", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "1,2,3,4,5", "chunk.metadata.test_types": "integration_testing,system_testing,acceptance_testing,performance_testing,regression_testing", "chunk.metadata.sections": "ISPE GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition),1 Introduction,1.1 Rationale for GAMP 5 Second Edition,2 Key Concepts,2.1 Overview", "chunk.metadata.document_title": "**\"GAMP 5 Second Edition: Risk-Based Compliance, Innovation, and Lifecycle Management for GxP Computerized Systems in Pharma 4.0 \u2013 A Comprehensive Framework for Digital Transformation, Quality Risk Management, and Patient-Centric Quality Systems\"**  \n\nThis comprehensive title integrates all key elements:  \n- **Core Focus:** GAMP 5\u2019s risk-based approach to GxP compliance and lifecycle management.  \n- **Key Themes:** Patient safety, data integrity, Agile/iterative methods, and emerging technologies (AI/ML, blockchain, cloud).  \n- **Industry Alignment:** Integration with Pharma 4.0, digital maturity, and regulatory frameworks (ISO, ASTM, FDA).  \n- **Updated Scope:** Emphasis on supplier involvement, critical thinking, and lifecycle management within a QMS.  \n- **Comprehensive Framework:** Quality Risk Management (QRM), validation, specification, verification, and critical thinking in regulated environments.  \n\nIt reflects the document\u2019s blend of regulatory guidance, technological advancement, and patient-centric quality systems, aligning with both traditional and Agile methodologies.", "chunk.metadata.excerpt_keywords": "Here are 10 unique keywords for the document, formatted as comma-separated:  \n\n**Keywords:** GAMP 5, risk-based compliance, computerized systems validation, Pharma 4.0, quality risk management (QRM), supplier assessment, lifecycle management, data integrity, Agile methodologies, regulatory frameworks"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.065801", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "0a52230799a552ad", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "08fd33889f1e8def", "name": "chromadb.chunk.10", "kind": "INTERNAL", "start_time": 1755776018066193000, "end_time": 1755776018066240100, "duration_ns": 47100, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 10, "chunk.node_id": "4335e520-6d9a-4e7d-aa08-e5274638be63", "chunk.score": 0.4318850326495772, "chunk.title": "Untitled Document", "chunk.type": "testing_methodology", "chunk.text_length": 6108, "chunk.has_embedding": false, "chunk.metadata.file_name": "testing_data.md", "chunk.metadata.file_path": "tests\\test_data\\gamp5_test_data\\testing_data.md", "chunk.metadata.collection": "gamp5", "chunk.metadata.ingestion_timestamp": "2025-08-09T10:22:46.690295+00:00", "chunk.metadata.type": "testing_methodology", "chunk.metadata.compliance_level": "regulatory", "chunk.metadata.gamp_categories": "", "chunk.metadata.test_types": "", "chunk.metadata.sections": "GAMP-5 Categorization - Testing Data,URS-001: Environmental Monitoring System (EMS),1. Introduction,2. Functional Requirements,3. Regulatory Requirements", "chunk.metadata.document_title": "\"Comprehensive Guide to GAMP-5 Categorization, Testing, and Advanced System Requirements for Environmental Monitoring, LIMS, MES, CDS, and Clinical Trial Management Systems in Pharmaceutical Operations\"", "chunk.metadata.excerpt_keywords": "GAMP-5, Environmental Monitoring System, LIMS, MES, CDS, Regulatory Requirements, Functional Requirements, Testing Methodology, Pharmaceutical Operations, Compliance Level"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.066266", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "08fd33889f1e8def", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "fe787e69ac305c3a", "name": "chromadb.search_collection.gamp5", "kind": "INTERNAL", "start_time": 1755776017380381000, "end_time": 1755776018066778600, "duration_ns": 686397600, "status": {"status_code": "UNSET", "description": null}, "attributes": {"collection.name": "gamp5", "collection.document_count": 71, "collection.nodes_retrieved": 10, "collection.retrieval_time_ms": 554.443}, "events": [{"name": "collection_search_complete", "timestamp": 1755776018066764800, "attributes": {"nodes_retrieved": 10, "retrieval_time_ms": 554.443, "top_score": 0.48970473038442924, "avg_score": 0.4481922073475599, "chunk_details": "[{\"rank\": 1, \"node_id\": \"3bd1baa0-935f-4ffb-8ecf-1bf60006f499\", \"score\": 0.48970473038442924, \"title\": \"Untitled Document\", \"type\": \"testing_methodology\", \"text_preview\": \"PHARMACEUTICAL SYSTEM REQUIREMENTS\\n\\nGAMP Category: Category 5 (Custom Application)\\nRisk Level: High\\n\\nFunctional Requirements:\\n1. User authentication required\\n2. Data integrity (ALCOA+ compliance)  \\n3.\", \"metadata\": {\"file_name\": \"test_urs.txt\", \"file_path\": \"tests\\\\test_data\\\\test_urs.txt\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.687328+00:00\", \"type\": \"testing_methodology\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"5\", \"test_types\": \"performance_testing,security_testing,validation_testing\", \"sections\": \"1. User authentication required,2. Data integrity (ALCOA+ compliance),3. Audit trail logging,4. Electronic signatures\", \"document_title\": \"Here\\u2019s a refined and comprehensive title that incorporates all critical elements while maintaining clarity and conciseness:  \\n\\n**\\\"Validation and Testing of a High-Risk Custom Pharmaceutical System: Ensuring ALCOA+ Compliance, Secure User Authentication, Audit Trails, and Electronic Signatures through Rigorous Functional, Performance, and Security Testing (GAMP Category 5)\\\"**  \\n\\n### Key Improvements:  \\n1. **Structure** \\u2013 Opens with the scope (*Validation and Testing*) and system type (*High-Risk Custom Pharmaceutical System*).  \\n2. **Compliance Focus** \\u2013 Explicitly highlights *ALCOA+* as the core framework.  \\n3. **Functional Requirements** \\u2013 Bundles *User Authentication, Audit Trails, and Electronic Signatures* as critical features.  \\n4. **Testing Rigor** \\u2013 Emphasizes *Functional, Performance, and Security Testing* as validation pillars.  \\n5. **Regulatory Context** \\u2013 Closes with *(GAMP Category 5)* to anchor the high-risk classification.  \\n\\nThis version balances technical precision with readability, ensuring alignment with regulatory expectations (e.g., FDA 21 CFR Part 11, EU Annex 11) while targeting stakeholders in validation, IT, and quality assurance.  \\n\\nWould you like further adjustments to emphasize specific aspects (e.g., risk management, scalability)?\", \"excerpt_keywords\": \"Validation, ALCOA+, User Authentication, Audit Trails, Electronic Signatures, GAMP Category 5, Performance Testing, Security Testing, Pharmaceutical System, Regulatory Compliance\"}, \"embedding_id\": null}, {\"rank\": 2, \"node_id\": \"81aefa78-eb80-409b-88be-8c75d6858ce0\", \"score\": 0.4769541150233713, \"title\": \"Untitled Document\", \"type\": \"testing_methodology\", \"text_preview\": \"PHARMACEUTICAL SYSTEM REQUIREMENTS\\n\\nGAMP Category: Category 5 (Custom Application)\\nRisk Level: High\\n\\nFunctional Requirements:\\n1. User authentication required\\n2. Data integrity (ALCOA+ compliance)  \\n3.\", \"metadata\": {\"file_name\": \"test_urs_hitl.txt\", \"file_path\": \"tests\\\\test_data\\\\test_urs_hitl.txt\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.689228+00:00\", \"type\": \"testing_methodology\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"5\", \"test_types\": \"performance_testing,security_testing,validation_testing\", \"sections\": \"1. User authentication required,2. Data integrity (ALCOA+ compliance),3. Audit trail logging,4. Electronic signatures\", \"document_title\": \"**\\\"High-Risk Custom Pharmaceutical System: Ensuring GAMP 5 Compliance with ALCOA+ Data Integrity, Robust User Authentication, Comprehensive Audit Trails, Secure Electronic Signatures, and Full-Scale Validation, Performance, and Security Testing\\\"**  \\n\\nThis comprehensive title encapsulates:  \\n- **Risk Level (High)**  \\n- **GAMP Category (5 - Custom Application)**  \\n- **Key Functional Requirements** (ALCOA+ Data Integrity, User Authentication, Audit Trails, Electronic Signatures)  \\n- **Testing Requirements** (Validation, Performance, Security Testing)  \\n- **HITL (Human-in-the-Loop) Test Trigger** for scenario-based evaluation.  \\n\\nThe title is designed to provide clarity and precision for stakeholders in pharmaceutical compliance, software validation, and regulatory adherence.\", \"excerpt_keywords\": \"GAMP 5, ALCOA+, pharmaceutical compliance, custom application, high-risk system, user authentication, audit trail, electronic signatures, validation testing, security testing\"}, \"embedding_id\": null}, {\"rank\": 3, \"node_id\": \"5b70b237-3851-43d3-942f-604651381597\", \"score\": 0.45425468888261966, \"title\": \"Untitled Document\", \"type\": \"testing_methodology\", \"text_preview\": \"PHARMACEUTICAL URS DOCUMENT - TEST VALIDATION SYSTEM\\n\\nDocument Name: Laboratory Information Management System (LIMS) \\nDocument Version: 2.1.0-VALIDATION\\nAuthor: Pharmaceutical Validation Team\\nDate: 20\", \"metadata\": {\"file_name\": \"test_pharmaceutical_urs.txt\", \"file_path\": \"tests\\\\test_data\\\\test_pharmaceutical_urs.txt\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.685423+00:00\", \"type\": \"testing_methodology\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"4,5\", \"test_types\": \"performance_testing\", \"sections\": \"1. Sample Management and Chain of Custody,2. Test Method Management,3. Quality Control and Release,4. Regulatory Compliance Features,5. Integration Requirements\", \"document_title\": \"A comprehensive and precise title for your document could be:  \\n\\n**\\\"Comprehensive User Requirements Specification (URS) for a Customized Laboratory Information Management System (LIMS) in FDA-Regulated Pharmaceutical Manufacturing: Ensuring Compliance with 21 CFR Part 11, ALCOA+ Principles, and GAMP 5 Guidelines\\\"**  \\n\\nThis title effectively captures:  \\n- The document type (**User Requirements Specification - URS**)  \\n- The system in focus (**Customized LIMS**)  \\n- The industry context (**FDA-regulated pharmaceutical manufacturing**)  \\n- Key compliance frameworks (**21 CFR Part 11, ALCOA+, GAMP 5**)  \\n\\nIf you prefer a slightly more concise version while retaining all critical elements, you could use:  \\n\\n**\\\"User Requirements Specification (URS) for a Pharmaceutical LIMS: Compliance with 21 CFR Part 11, ALCOA+, and GAMP 5 in FDA-Regulated Manufacturing\\\"**  \\n\\nBoth options ensure regulatory and technical clarity while maintaining readability. Let me know if you'd like further refinements!\", \"excerpt_keywords\": \"Keywords: LIMS, Pharmaceutical Validation, 21 CFR Part 11, GAMP-5, ALCOA+, FDA Compliance, Electronic Records, Data Integrity, Sample Management, Quality Control\"}, \"embedding_id\": null}, {\"rank\": 4, \"node_id\": \"25774d54-c90c-4c9b-ab00-ebba95074b65\", \"score\": 0.44686272018628603, \"title\": \"Untitled Document\", \"type\": \"regulatory_guidance\", \"text_preview\": \"Login: validuser/wrongpassword\\n   Expected: Access denied, \\\"Invalid credentials\\\"\\n   Actual: _______________\\n   \\n2. Login: wronguser/validpassword  \\n   Expected: Access denied, \\\"Invalid credentials\\\"\\n  \", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.650626+00:00\", \"type\": \"regulatory_guidance\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**\\\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \\u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\\\"**  \\n\\nThis title effectively combines:  \\n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \\n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \\n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \\n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \\n\\n*Alternative Concise Version*:  \\n**\\\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\\\"**  \\n\\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.\", \"excerpt_keywords\": \"Here are 10 unique keywords for this document, formatted as comma-separated:  \\n\\n**Keywords**: GAMP validation, OQ test scripts, pharmaceutical compliance, 21 CFR Part 11, ALCOA+, risk-based testing, computerized systems, PID algorithm, performance testing, electronic batch records\"}, \"embedding_id\": null}, {\"rank\": 5, \"node_id\": \"0f4371af-dc06-4b2a-85ae-3dd6f2e3f392\", \"score\": 0.4459338823697484, \"title\": \"Untitled Document\", \"type\": \"regulatory_guidance\", \"text_preview\": \"Recipe Management (15 test cases)\\n2. Batch Execution (25 test cases)\\n3. Electronic Signatures (10 test cases)\\n4. Audit Trail (12 test cases)\\n5. Reporting (8 test cases)\\n6. Integration (20 test cases)\\n\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.650626+00:00\", \"type\": \"regulatory_guidance\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**\\\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \\u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\\\"**  \\n\\nThis title effectively combines:  \\n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \\n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \\n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \\n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \\n\\n*Alternative Concise Version*:  \\n**\\\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\\\"**  \\n\\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.\", \"excerpt_keywords\": \"GAMP 5, 21 CFR Part 11, OQ Test Scripts, Pharmaceutical Validation, Risk-Based Testing, ALCOA+, Computer Software Assurance, Electronic Signatures, Audit Trail, Data Integrity\"}, \"embedding_id\": null}, {\"rank\": 6, \"node_id\": \"c861432b-4379-4525-9bfb-e7b99e4db37b\", \"score\": 0.4380896854247896, \"title\": \"Untitled Document\", \"type\": \"regulatory_guidance\", \"text_preview\": \"- **URS-CTMS-013**: Custom encryption beyond platform standards for certain jurisdictions.\\n\\n---\\n\\n## URS-V04: Electronic Document Management System (EDMS)\\n**Target Category**: 4 (Clear)\\n**System Type**\", \"metadata\": {\"file_name\": \"validation_data.md\", \"file_path\": \"tests\\\\test_data\\\\gamp5_test_data\\\\validation_data.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.691302+00:00\", \"type\": \"regulatory_guidance\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"\", \"test_types\": \"\", \"sections\": \"GAMP-5 Categorization - Validation Data,URS-V01: Manufacturing Execution System (MES),1. Introduction,2. Functional Requirements,3. Regulatory Requirements\", \"document_title\": \"**Comprehensive Guide to GAMP-5 Categorization, Validation, and Regulatory Compliance for GxP-Compliant Systems: EDMS, CTMS, PLC-Based Autoclave Controller, and Custom Encryption in Manufacturing, Chromatography, Clinical Trials, and Document Management**  \\n\\nThis title comprehensively captures the scope of the document, including:  \\n- **GAMP-5 Categorization and Validation Requirements** for both custom and commercial systems.  \\n- **Key GxP-Compliant Systems**: Electronic Document Management System (EDMS), Clinical Trial Management System (CTMS), and PLC-Based Autoclave Controller.  \\n- **Custom Encryption (URS-CTMS-013)** for specific jurisdictional needs.  \\n- **Regulatory Compliance** with standards such as 21 CFR Part 11, audit trails, and user access controls.  \\n- **Functional and System Requirements** for integration, workflows, and process control across manufacturing, chromatography, clinical trials, and document management.\", \"excerpt_keywords\": \"GAMP-5, validation, regulatory compliance, GxP, EDMS, CTMS, autoclave controller, 21 CFR Part 11, encryption, PLC\"}, \"embedding_id\": null}, {\"rank\": 7, \"node_id\": \"855933ad-883d-4ecd-baf8-b34d2ce56d94\", \"score\": 0.4332589203651332, \"title\": \"Untitled Document\", \"type\": \"regulatory_guidance\", \"text_preview\": \"# Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation\\n\\nOperational Qualification (OQ) test scripts form the backbone of pharmaceutical computerized systems validation, ensurin\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.650626+00:00\", \"type\": \"regulatory_guidance\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**\\\"Pharmaceutical Computerized Systems Validation: A Comprehensive Guide to GAMP Category 3, 4, and 5 OQ Test Scripts with Real-World Examples for LIMS, MES, ERP, EBR, DMS, and Custom Security Modules \\u2013 Integrating Risk-Based Testing, 21 CFR Part 11, GAMP 5, and ALCOA+ Compliance\\\"**  \\n\\nThis title effectively combines:  \\n1. **Scope & Focus**: Pharmaceutical validation, GAMP 3-5, OQ test scripts.  \\n2. **Content Type**: Practical examples across diverse systems (LIMS, MES, ERP, etc.).  \\n3. **Key Themes**: Risk-based testing, regulatory compliance (21 CFR Part 11, GAMP 5), ALCOA+ data integrity.  \\n4. **Unique Entities**: Explicit mention of critical modules (Batch Execution, E-Signatures, Audit Trails, etc.).  \\n\\n*Alternative Concise Version*:  \\n**\\\"GAMP 3-5 Validation in Pharma: Risk-Based OQ Test Scripts for 21 CFR Part 11, ALCOA+, and Critical System Modules\\\"**  \\n\\nBoth versions ensure clarity, regulatory relevance, and practical applicability while balancing detail and readability.\", \"excerpt_keywords\": \"GAMP validation, OQ test scripts, pharmaceutical systems, 21 CFR Part 11, ALCOA+, computerized systems, risk-based testing, LIMS validation, GAMP categories, regulatory compliance\"}, \"embedding_id\": null}, {\"rank\": 8, \"node_id\": \"b5003a9b-e944-419b-ab9f-db545db87a10\", \"score\": 0.4328670082303556, \"title\": \"Untitled Document\", \"type\": \"testing_methodology\", \"text_preview\": \"PHARMACEUTICAL SYSTEM REQUIREMENTS - COMPREHENSIVE TEST\\n\\nSystem Name: Clinical Data Management System (CDMS)\\nGAMP Category: Category 5 (Custom Application)\\nRisk Level: High\\nGxP Impact: Direct impact o\", \"metadata\": {\"file_name\": \"test_urs_comprehensive.txt\", \"file_path\": \"tests\\\\test_data\\\\test_urs_comprehensive.txt\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.687328+00:00\", \"type\": \"testing_methodology\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"5\", \"test_types\": \"acceptance_testing,regression_testing\", \"sections\": \"1. USER AUTHENTICATION & ACCESS CONTROL,2. DATA INTEGRITY (ALCOA+ COMPLIANCE),3. ELECTRONIC SIGNATURES,4. AUDIT TRAIL SYSTEM,5. DATA BACKUP & RECOVERY\", \"document_title\": \"**\\\"Comprehensive Validation and Compliance Framework for a High-Risk Clinical Data Management System (CDMS): Ensuring ALCOA+ Data Integrity, 21 CFR Part 11 Compliance, GAMP 5 Standards, and Robust Security Protocols in Accordance with ISO 27001, HIPAA, and ICH E6 Guidelines\\\"**  \\n\\nThis title comprehensively encapsulates:  \\n- **System Type**: Clinical Data Management System (CDMS)  \\n- **Risk Level**: High-risk, GxP-impactful  \\n- **Key Standards**: ALCOA+, 21 CFR Part 11, GAMP 5, ISO 27001, HIPAA, ICH E6  \\n- **Core Themes**: Data integrity, electronic signatures, audit trails, security (encryption, MFA), validation (IQ/OQ/PQ), and performance metrics.  \\n- **Unique Entities**: Multi-factor authentication, RBAC, audit trail immutability, backup/recovery (RTO/RPO), and compliance frameworks.  \\n\\nThe title emphasizes the system\\u2019s regulatory rigor, risk management, and end-to-end operational requirements, ensuring clarity and alignment with industry standards.\", \"excerpt_keywords\": \"Here are 10 unique keywords for this document, formatted as comma-separated:  \\n\\n**Keywords**: Clinical Data Management System, ALCOA+ Compliance, 21 CFR Part 11, GAMP 5, Electronic Signatures, Audit Trail Immutability, Data Integrity, ISO 27001, HIPAA, Risk-Based Validation\"}, \"embedding_id\": null}, {\"rank\": 9, \"node_id\": \"fc56c7a3-26b3-4aa1-a873-bc51e871fc3d\", \"score\": 0.43211128995928877, \"title\": \"Untitled Document\", \"type\": \"regulatory_guidance\", \"text_preview\": \"Testing should be:\\n\\n- **Risk-Based**: Testing effort should be focused on high-risk areas\\n- **Comprehensive**: Testing should cover all system functions and requirements\\n- **Documented**: Testing shou\", \"metadata\": {\"file_name\": \"ISPE - GAMP 5_ A Risk-Based Approach to Compliant GxP Computerized_short.md\", \"file_path\": \"tests\\\\test_data\\\\ISPE - GAMP 5_ A Risk-Based Approach to Compliant GxP Computerized_short.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.624352+00:00\", \"type\": \"regulatory_guidance\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"1,2,3,4,5\", \"test_types\": \"integration_testing,system_testing,acceptance_testing,performance_testing,regression_testing\", \"sections\": \"ISPE GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition),1 Introduction,1.1 Rationale for GAMP 5 Second Edition,2 Key Concepts,2.1 Overview\", \"document_title\": \"**\\\"GAMP 5 Second Edition: Risk-Based Compliance, Innovation, and Lifecycle Management for GxP Computerized Systems in Pharma 4.0 \\u2013 A Comprehensive Framework for Digital Transformation, Quality Risk Management, and Patient-Centric Quality Systems\\\"**  \\n\\nThis comprehensive title integrates all key elements:  \\n- **Core Focus:** GAMP 5\\u2019s risk-based approach to GxP compliance and lifecycle management.  \\n- **Key Themes:** Patient safety, data integrity, Agile/iterative methods, and emerging technologies (AI/ML, blockchain, cloud).  \\n- **Industry Alignment:** Integration with Pharma 4.0, digital maturity, and regulatory frameworks (ISO, ASTM, FDA).  \\n- **Updated Scope:** Emphasis on supplier involvement, critical thinking, and lifecycle management within a QMS.  \\n- **Comprehensive Framework:** Quality Risk Management (QRM), validation, specification, verification, and critical thinking in regulated environments.  \\n\\nIt reflects the document\\u2019s blend of regulatory guidance, technological advancement, and patient-centric quality systems, aligning with both traditional and Agile methodologies.\", \"excerpt_keywords\": \"Here are 10 unique keywords for the document, formatted as comma-separated:  \\n\\n**Keywords:** GAMP 5, risk-based compliance, computerized systems validation, Pharma 4.0, quality risk management (QRM), supplier assessment, lifecycle management, data integrity, Agile methodologies, regulatory frameworks\"}, \"embedding_id\": null}, {\"rank\": 10, \"node_id\": \"4335e520-6d9a-4e7d-aa08-e5274638be63\", \"score\": 0.4318850326495772, \"title\": \"Untitled Document\", \"type\": \"testing_methodology\", \"text_preview\": \"# GAMP-5 Categorization - Testing Data\\n\\nThis file contains a set of User Requirements Specifications (URS) to be used for **testing** the GAMP-5 categorization agent. The examples are designed to cove\", \"metadata\": {\"file_name\": \"testing_data.md\", \"file_path\": \"tests\\\\test_data\\\\gamp5_test_data\\\\testing_data.md\", \"collection\": \"gamp5\", \"ingestion_timestamp\": \"2025-08-09T10:22:46.690295+00:00\", \"type\": \"testing_methodology\", \"compliance_level\": \"regulatory\", \"gamp_categories\": \"\", \"test_types\": \"\", \"sections\": \"GAMP-5 Categorization - Testing Data,URS-001: Environmental Monitoring System (EMS),1. Introduction,2. Functional Requirements,3. Regulatory Requirements\", \"document_title\": \"\\\"Comprehensive Guide to GAMP-5 Categorization, Testing, and Advanced System Requirements for Environmental Monitoring, LIMS, MES, CDS, and Clinical Trial Management Systems in Pharmaceutical Operations\\\"\", \"excerpt_keywords\": \"GAMP-5, Environmental Monitoring System, LIMS, MES, CDS, Regulatory Requirements, Functional Requirements, Testing Methodology, Pharmaceutical Operations, Compliance Level\"}, \"embedding_id\": null}]"}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.066816", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "f96634f49eb02b36", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "10751d8a5ff7ace7", "name": "chromadb.query", "kind": "INTERNAL", "start_time": 1755776018346720700, "end_time": 1755776018374718800, "duration_ns": 27998100, "status": {"status_code": "UNSET", "description": null}, "attributes": {"vector_db.operation": "query", "compliance.gamp5.vector_operation": true, "compliance.pharmaceutical": true, "data_integrity.vector_search": true, "chromadb.query.n_results": 10, "chromadb.query.status": "success", "chromadb.query.result_count": 0, "chromadb.query.avg_distance": 0}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.374817", "span_type": "vector_database", "database_type": "chromadb", "operation": "query", "result_count": 0, "avg_distance": 0}
{"span_id": "10751d8a5ff7ace7", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "fe787e69ac305c3a", "name": "chromadb.search_collection.regulatory", "kind": "INTERNAL", "start_time": 1755776018067422200, "end_time": 1755776018376366500, "duration_ns": 308944300, "status": {"status_code": "UNSET", "description": null}, "attributes": {"collection.name": "regulatory", "collection.document_count": 0, "collection.nodes_retrieved": 0, "collection.retrieval_time_ms": 304.916}, "events": [{"name": "collection_search_complete", "timestamp": 1755776018376354500, "attributes": {"nodes_retrieved": 0, "retrieval_time_ms": 304.916, "top_score": 0.0, "avg_score": 0.0, "chunk_details": "[]"}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.376438", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "5adc549a9ca1b902", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "555a86c11ee11e03", "name": "chromadb.query", "kind": "INTERNAL", "start_time": 1755776018666521100, "end_time": 1755776018696910900, "duration_ns": 30389800, "status": {"status_code": "UNSET", "description": null}, "attributes": {"vector_db.operation": "query", "compliance.gamp5.vector_operation": true, "compliance.pharmaceutical": true, "data_integrity.vector_search": true, "chromadb.query.n_results": 10, "chromadb.query.status": "success", "chromadb.query.result_count": 0, "chromadb.query.avg_distance": 0}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.697014", "span_type": "vector_database", "database_type": "chromadb", "operation": "query", "result_count": 0, "avg_distance": 0}
{"span_id": "555a86c11ee11e03", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "fe787e69ac305c3a", "name": "chromadb.search_collection.sops", "kind": "INTERNAL", "start_time": 1755776018377067600, "end_time": 1755776018698812500, "duration_ns": 321744900, "status": {"status_code": "UNSET", "description": null}, "attributes": {"collection.name": "sops", "collection.document_count": 0, "collection.nodes_retrieved": 0, "collection.retrieval_time_ms": 317.241}, "events": [{"name": "collection_search_complete", "timestamp": 1755776018698799800, "attributes": {"nodes_retrieved": 0, "retrieval_time_ms": 317.241, "top_score": 0.0, "avg_score": 0.0, "chunk_details": "[]"}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:38.698867", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "d3a226e71f654c3c", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "8fcda1c65b8db022", "name": "chromadb.query", "kind": "INTERNAL", "start_time": 1755776019138765800, "end_time": 1755776019170552600, "duration_ns": 31786800, "status": {"status_code": "UNSET", "description": null}, "attributes": {"vector_db.operation": "query", "compliance.gamp5.vector_operation": true, "compliance.pharmaceutical": true, "data_integrity.vector_search": true, "chromadb.query.n_results": 10, "chromadb.query.status": "success", "chromadb.query.result_count": 8, "chromadb.query.avg_distance": 0.8248384743928909}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.170656", "span_type": "vector_database", "database_type": "chromadb", "operation": "query", "result_count": 8, "avg_distance": 0.8248384743928909}
{"span_id": "2ea7b711144ec09e", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "8fcda1c65b8db022", "name": "chromadb.chunk.1", "kind": "INTERNAL", "start_time": 1755776019174365600, "end_time": 1755776019174427300, "duration_ns": 61700, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 1, "chunk.node_id": "055be98e-d369-4395-b0f1-fc1d3853c2cb", "chunk.score": 0.45589814361414466, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6492, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:07:38.359212+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "Integrated GAMP\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\u202fCFR\u202fPart\u202f11 Security Compliance.", "chunk.metadata.excerpt_keywords": "OQ, GAMP\u202f5, 21\u202fCFR\u202fPart\u202f11, electronic batch record, data integrity, risk\u2011based testing, scripted testing, audit trail, performance qualification, validation framework"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.174485", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "59937e0ca786b058", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "8fcda1c65b8db022", "name": "chromadb.chunk.2", "kind": "INTERNAL", "start_time": 1755776019175168200, "end_time": 1755776019175217900, "duration_ns": 49700, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 2, "chunk.node_id": "baa66ce3-6a40-44a3-817f-23798b6425d1", "chunk.score": 0.44746683921026736, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6679, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:07:38.359212+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "Integrated GAMP\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\u202fCFR\u202fPart\u202f11 Security Compliance.", "chunk.metadata.excerpt_keywords": "Operational Qualification, GAMP, pharmaceutical validation, environmental monitoring, LIMS, HPLC, data integrity, 21\u202fCFR\u202fPart\u202f11, risk assessment, test scripts"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.175250", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "8cf36c41eee91333", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "8fcda1c65b8db022", "name": "chromadb.chunk.3", "kind": "INTERNAL", "start_time": 1755776019175684300, "end_time": 1755776019175730200, "duration_ns": 45900, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 3, "chunk.node_id": "db20acd0-9443-40b7-bfb1-37515be07960", "chunk.score": 0.4450475595215796, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6492, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:09:48.217837+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**Comprehensive OQ Test\u2011Script Guide for Pharmaceutical Computerized Systems \u2013 GAMP\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\u2011Control Algorithms, Data\u2011Analysis Performance, Multi\u2011System Automation Integration, Integrated Batch\u2011Workflow Validation, 21\u202fCFR\u202fPart\u202f11 Compliance, Test\u2011Format Strategies & Data\u2011Integrity Verification)**", "chunk.metadata.excerpt_keywords": "OQ test scripts, GAMP\u202f5, 21\u202fCFR\u202fPart\u202f11, data integrity, MES\u2011LIMS integration, Electronic Batch Record (EBR), performance testing, risk\u2011based validation, audit trail verification, critical process parameter monitoring"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.175760", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "b4d6b1df8b6db49f", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "8fcda1c65b8db022", "name": "chromadb.chunk.4", "kind": "INTERNAL", "start_time": 1755776019176143600, "end_time": 1755776019176188200, "duration_ns": 44600, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 4, "chunk.node_id": "c31d1974-a063-4a60-a3dc-6405574b1df7", "chunk.score": 0.4440115124177413, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6679, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:09:48.217837+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**Comprehensive OQ Test\u2011Script Guide for Pharmaceutical Computerized Systems \u2013 GAMP\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\u2011Control Algorithms, Data\u2011Analysis Performance, Multi\u2011System Automation Integration, Integrated Batch\u2011Workflow Validation, 21\u202fCFR\u202fPart\u202f11 Compliance, Test\u2011Format Strategies & Data\u2011Integrity Verification)**", "chunk.metadata.excerpt_keywords": "Operational Qualification, GAMP\u202f5, Pharmaceutical computerized systems validation, Category\u202f3 non\u2011configured systems, Category\u202f4 configured systems, Category\u202f5 custom software, Environmental Monitoring System testing, 21\u202fCFR\u202fPart\u202f11 compliance, Data integrity verification, Test script formats"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.176214", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "e3f6465bb2b03c5e", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "8fcda1c65b8db022", "name": "chromadb.chunk.5", "kind": "INTERNAL", "start_time": 1755776019176588600, "end_time": 1755776019176632600, "duration_ns": 44000, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 5, "chunk.node_id": "72bd7c48-cfce-4768-ad65-7727b5b1f001", "chunk.score": 0.44101919634203446, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6281, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:07:38.359212+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "Integrated GAMP\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\u202fCFR\u202fPart\u202f11 Security Compliance.", "chunk.metadata.excerpt_keywords": "Keywords: GAMP\u202f5, Operational Qualification, Pharmaceutical Validation, LIMS, MES, ERP, 21\u202fCFR\u202fPart\u202f11, Test Scripts, Configured Systems, Custom Systems"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.176658", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "6cd7d90cdc9a9e2a", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "8fcda1c65b8db022", "name": "chromadb.chunk.6", "kind": "INTERNAL", "start_time": 1755776019177054500, "end_time": 1755776019177099000, "duration_ns": 44500, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 6, "chunk.node_id": "0ef52e54-af27-4b6a-8232-986db2b4b453", "chunk.score": 0.4348313385823402, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 6281, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:09:48.217837+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**Comprehensive OQ Test\u2011Script Guide for Pharmaceutical Computerized Systems \u2013 GAMP\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\u2011Control Algorithms, Data\u2011Analysis Performance, Multi\u2011System Automation Integration, Integrated Batch\u2011Workflow Validation, 21\u202fCFR\u202fPart\u202f11 Compliance, Test\u2011Format Strategies & Data\u2011Integrity Verification)**", "chunk.metadata.excerpt_keywords": "Keywords: OQ\u2011test\u2011scripts, GAMP\u2011categories, LIMS\u2011validation, MES\u2011batch\u2011record, ERP\u2011quality\u2011module, Power\u2011Loss\u2011Recovery, Exploratory\u2011Testing, 21CFR\u2011Part\u201111, Custom\u2011Security\u2011module, Data\u2011Integrity\u2011verification"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.177128", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "facf8acc996f86e5", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "8fcda1c65b8db022", "name": "chromadb.chunk.7", "kind": "INTERNAL", "start_time": 1755776019177495600, "end_time": 1755776019177541700, "duration_ns": 46100, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 7, "chunk.node_id": "60697cad-6835-47f0-b885-cd0e69ecc10c", "chunk.score": 0.42090292752030606, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 5246, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:07:38.359212+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "Integrated GAMP\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\u202fCFR\u202fPart\u202f11 Security Compliance.", "chunk.metadata.excerpt_keywords": "Operational Qualification, GAMP\u202f5, Security Module Validation, Authentication Testing, PID Control Algorithm, Performance Load Testing, Audit Trail Verification, Role\u2011Based Authorization, Data Integrity under Stress, Multi\u2011System Integration Testing"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.177567", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "ef45f7c3d30b5837", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "8fcda1c65b8db022", "name": "chromadb.chunk.8", "kind": "INTERNAL", "start_time": 1755776019177957300, "end_time": 1755776019178001900, "duration_ns": 44600, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chunk.rank": 8, "chunk.node_id": "0d555a4e-9db2-4eff-9ac1-b87d4422a59d", "chunk.score": 0.418627742692365, "chunk.title": "Untitled Document", "chunk.type": "best_practices", "chunk.text_length": 5246, "chunk.has_embedding": false, "chunk.metadata.file_name": "OQ_examples.md", "chunk.metadata.file_path": "C:\\Users\\anteb\\Desktop\\Courses\\Projects\\thesis_project\\main\\tests\\test_data\\OQ_examples.md", "chunk.metadata.collection": "best_practices", "chunk.metadata.ingestion_timestamp": "2025-08-08T10:09:48.217837+00:00", "chunk.metadata.type": "best_practices", "chunk.metadata.compliance_level": "recommended", "chunk.metadata.gamp_categories": "3,4,5", "chunk.metadata.test_types": "integration_testing,performance_testing", "chunk.metadata.sections": "Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen", "chunk.metadata.document_title": "**Comprehensive OQ Test\u2011Script Guide for Pharmaceutical Computerized Systems \u2013 GAMP\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\u2011Control Algorithms, Data\u2011Analysis Performance, Multi\u2011System Automation Integration, Integrated Batch\u2011Workflow Validation, 21\u202fCFR\u202fPart\u202f11 Compliance, Test\u2011Format Strategies & Data\u2011Integrity Verification)**", "chunk.metadata.excerpt_keywords": "Keywords: OQ testing, GAMP5, LIMS security, PID control algorithm, performance testing, integration testing, data integrity, audit trail, multi-system automation, pharmaceutical validation"}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.178027", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "8fcda1c65b8db022", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "fe787e69ac305c3a", "name": "chromadb.search_collection.best_practices", "kind": "INTERNAL", "start_time": 1755776018699453600, "end_time": 1755776019178498000, "duration_ns": 479044400, "status": {"status_code": "UNSET", "description": null}, "attributes": {"collection.name": "best_practices", "collection.document_count": 8, "collection.nodes_retrieved": 8, "collection.retrieval_time_ms": 369.5}, "events": [{"name": "collection_search_complete", "timestamp": 1755776019178487600, "attributes": {"nodes_retrieved": 8, "retrieval_time_ms": 369.5, "top_score": 0.45589814361414466, "avg_score": 0.4384756574875973, "chunk_details": "[{\"rank\": 1, \"node_id\": \"055be98e-d369-4395-b0f1-fc1d3853c2cb\", \"score\": 0.45589814361414466, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"Create batch order in MES\\n2. Transfer to LIMS for testing\\n3. Execute analyses in LIMS\\n4. Return results to MES\\n5. Trigger analytics calculations\\n6. Generate integrated batch report\\n\\nVerification Point\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:07:38.359212+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"Integrated GAMP\\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\\u202fCFR\\u202fPart\\u202f11 Security Compliance.\", \"excerpt_keywords\": \"OQ, GAMP\\u202f5, 21\\u202fCFR\\u202fPart\\u202f11, electronic batch record, data integrity, risk\\u2011based testing, scripted testing, audit trail, performance qualification, validation framework\"}, \"embedding_id\": null}, {\"rank\": 2, \"node_id\": \"baa66ce3-6a40-44a3-817f-23798b6425d1\", \"score\": 0.44746683921026736, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"# Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation\\n\\nOperational Qualification (OQ) test scripts form the backbone of pharmaceutical computerized systems validation, ensurin\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:07:38.359212+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"Integrated GAMP\\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\\u202fCFR\\u202fPart\\u202f11 Security Compliance.\", \"excerpt_keywords\": \"Operational Qualification, GAMP, pharmaceutical validation, environmental monitoring, LIMS, HPLC, data integrity, 21\\u202fCFR\\u202fPart\\u202f11, risk assessment, test scripts\"}, \"embedding_id\": null}, {\"rank\": 3, \"node_id\": \"db20acd0-9443-40b7-bfb1-37515be07960\", \"score\": 0.4450475595215796, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"Create batch order in MES\\n2. Transfer to LIMS for testing\\n3. Execute analyses in LIMS\\n4. Return results to MES\\n5. Trigger analytics calculations\\n6. Generate integrated batch report\\n\\nVerification Point\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:09:48.217837+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**Comprehensive OQ Test\\u2011Script Guide for Pharmaceutical Computerized Systems \\u2013 GAMP\\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\\u2011Control Algorithms, Data\\u2011Analysis Performance, Multi\\u2011System Automation Integration, Integrated Batch\\u2011Workflow Validation, 21\\u202fCFR\\u202fPart\\u202f11 Compliance, Test\\u2011Format Strategies & Data\\u2011Integrity Verification)**\", \"excerpt_keywords\": \"OQ test scripts, GAMP\\u202f5, 21\\u202fCFR\\u202fPart\\u202f11, data integrity, MES\\u2011LIMS integration, Electronic Batch Record (EBR), performance testing, risk\\u2011based validation, audit trail verification, critical process parameter monitoring\"}, \"embedding_id\": null}, {\"rank\": 4, \"node_id\": \"c31d1974-a063-4a60-a3dc-6405574b1df7\", \"score\": 0.4440115124177413, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"# Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation\\n\\nOperational Qualification (OQ) test scripts form the backbone of pharmaceutical computerized systems validation, ensurin\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:09:48.217837+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**Comprehensive OQ Test\\u2011Script Guide for Pharmaceutical Computerized Systems \\u2013 GAMP\\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\\u2011Control Algorithms, Data\\u2011Analysis Performance, Multi\\u2011System Automation Integration, Integrated Batch\\u2011Workflow Validation, 21\\u202fCFR\\u202fPart\\u202f11 Compliance, Test\\u2011Format Strategies & Data\\u2011Integrity Verification)**\", \"excerpt_keywords\": \"Operational Qualification, GAMP\\u202f5, Pharmaceutical computerized systems validation, Category\\u202f3 non\\u2011configured systems, Category\\u202f4 configured systems, Category\\u202f5 custom software, Environmental Monitoring System testing, 21\\u202fCFR\\u202fPart\\u202f11 compliance, Data integrity verification, Test script formats\"}, \"embedding_id\": null}, {\"rank\": 5, \"node_id\": \"72bd7c48-cfce-4768-ad65-7727b5b1f001\", \"score\": 0.44101919634203446, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"Power Loss Recovery\\n   - Start logging, interrupt power\\n   - Verify data recovery\\n   - Accept: No data loss\\n\\nPart B - Exploratory Testing:\\n- Various sampling rates\\n- Multiple sensor inputs\\n- Export fo\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:07:38.359212+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"Integrated GAMP\\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\\u202fCFR\\u202fPart\\u202f11 Security Compliance.\", \"excerpt_keywords\": \"Keywords: GAMP\\u202f5, Operational Qualification, Pharmaceutical Validation, LIMS, MES, ERP, 21\\u202fCFR\\u202fPart\\u202f11, Test Scripts, Configured Systems, Custom Systems\"}, \"embedding_id\": null}, {\"rank\": 6, \"node_id\": \"0ef52e54-af27-4b6a-8232-986db2b4b453\", \"score\": 0.4348313385823402, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"Power Loss Recovery\\n   - Start logging, interrupt power\\n   - Verify data recovery\\n   - Accept: No data loss\\n\\nPart B - Exploratory Testing:\\n- Various sampling rates\\n- Multiple sensor inputs\\n- Export fo\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:09:48.217837+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**Comprehensive OQ Test\\u2011Script Guide for Pharmaceutical Computerized Systems \\u2013 GAMP\\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\\u2011Control Algorithms, Data\\u2011Analysis Performance, Multi\\u2011System Automation Integration, Integrated Batch\\u2011Workflow Validation, 21\\u202fCFR\\u202fPart\\u202f11 Compliance, Test\\u2011Format Strategies & Data\\u2011Integrity Verification)**\", \"excerpt_keywords\": \"Keywords: OQ\\u2011test\\u2011scripts, GAMP\\u2011categories, LIMS\\u2011validation, MES\\u2011batch\\u2011record, ERP\\u2011quality\\u2011module, Power\\u2011Loss\\u2011Recovery, Exploratory\\u2011Testing, 21CFR\\u2011Part\\u201111, Custom\\u2011Security\\u2011module, Data\\u2011Integrity\\u2011verification\"}, \"embedding_id\": null}, {\"rank\": 7, \"node_id\": \"60697cad-6835-47f0-b885-cd0e69ecc10c\", \"score\": 0.42090292752030606, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"### Custom LIMS Security Module - Comprehensive Robust Format\\n\\nThis detailed script demonstrates the rigor required for custom-developed security functions:\\n\\n```\\nTest Script OQ-LIMS-001: User Access C\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:07:38.359212+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"Integrated GAMP\\u202f5 OQ/Performance Qualification Test Suite for Pharmaceutical Computerized Systems: Comprehensive Validation Framework for LIMS, MES, ERP, EBR, Instrumentation (Environmental Monitoring, HPLC, Laboratory Balance), Data Acquisition, Statistical Analysis, and 21\\u202fCFR\\u202fPart\\u202f11 Security Compliance.\", \"excerpt_keywords\": \"Operational Qualification, GAMP\\u202f5, Security Module Validation, Authentication Testing, PID Control Algorithm, Performance Load Testing, Audit Trail Verification, Role\\u2011Based Authorization, Data Integrity under Stress, Multi\\u2011System Integration Testing\"}, \"embedding_id\": null}, {\"rank\": 8, \"node_id\": \"0d555a4e-9db2-4eff-9ac1-b87d4422a59d\", \"score\": 0.418627742692365, \"title\": \"Untitled Document\", \"type\": \"best_practices\", \"text_preview\": \"### Custom LIMS Security Module - Comprehensive Robust Format\\n\\nThis detailed script demonstrates the rigor required for custom-developed security functions:\\n\\n```\\nTest Script OQ-LIMS-001: User Access C\", \"metadata\": {\"file_name\": \"OQ_examples.md\", \"file_path\": \"C:\\\\Users\\\\anteb\\\\Desktop\\\\Courses\\\\Projects\\\\thesis_project\\\\main\\\\tests\\\\test_data\\\\OQ_examples.md\", \"collection\": \"best_practices\", \"ingestion_timestamp\": \"2025-08-08T10:09:48.217837+00:00\", \"type\": \"best_practices\", \"compliance_level\": \"recommended\", \"gamp_categories\": \"3,4,5\", \"test_types\": \"integration_testing,performance_testing\", \"sections\": \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation,Understanding GAMP categories and their validation requirements,GAMP Category 3: Non-configured systems test scripts,Environmental Monitoring System - Robust Scripted Format,1. Navigate to sensor configuration screen\", \"document_title\": \"**Comprehensive OQ Test\\u2011Script Guide for Pharmaceutical Computerized Systems \\u2013 GAMP\\u202f5 Validation of LIMS, MES, ERP, EBR & DMS (Including Power\\u2011Loss Recovery, Exploratory Testing, Custom Security & Process\\u2011Control Algorithms, Data\\u2011Analysis Performance, Multi\\u2011System Automation Integration, Integrated Batch\\u2011Workflow Validation, 21\\u202fCFR\\u202fPart\\u202f11 Compliance, Test\\u2011Format Strategies & Data\\u2011Integrity Verification)**\", \"excerpt_keywords\": \"Keywords: OQ testing, GAMP5, LIMS security, PID control algorithm, performance testing, integration testing, data integrity, audit trail, multi-system automation, pharmaceutical validation\"}, \"embedding_id\": null}]"}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.178529", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "fe787e69ac305c3a", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": "700f84afd2d392c0", "name": "chromadb.search_documents", "kind": "INTERNAL", "start_time": 1755776015861471300, "end_time": 1755776019179144300, "duration_ns": 3317673000, "status": {"status_code": "UNSET", "description": null}, "attributes": {"chromadb.query": "GAMP Category 4 validation testing functional_requirements validation_requirements", "chromadb.query_length": 82, "chromadb.query_embedding_time_ms": 1518.511, "chromadb.query_embedding_dimension": 1536, "chromadb.collections": "[\"gamp5\", \"regulatory\", \"sops\", \"best_practices\"]", "chromadb.collection_count": 4, "chromadb.gamp_category": "4", "chromadb.max_documents": 10, "chromadb.context_depth": "standard", "chromadb.search_scope": "{}", "chromadb.total_results": 18, "chromadb.final_results": 10, "chromadb.success": true, "chromadb.average_relevance_score": 0.4547153387952222, "chromadb.top_relevance_score": 0.48970473038442924}, "events": [{"name": "query_generated", "timestamp": 1755776017380250600, "attributes": {"query_text": "GAMP Category 4 validation testing functional_requirements validation_requirements", "query_parts": "[\"GAMP\", \"Category\", \"4\", \"validation\", \"testing\", \"functional_requirements\", \"validation_requirements\"]", "embedding_time_ms": 1518.511, "embedding_norm": 0.999999994124102}}, {"name": "search_results_summary", "timestamp": 1755776019179119900, "attributes": {"total_documents": 10, "collections_searched": "[\"gamp5\", \"regulatory\", \"sops\", \"best_practices\"]", "document_types": "[\"testing_methodology\", \"best_practices\", \"regulatory_guidance\"]", "gamp_categories_found": "[\"3\", \"4\", \"5\"]"}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.179184", "span_type": "vector_database", "database_type": "chromadb"}
{"span_id": "700f84afd2d392c0", "trace_id": "0d4f59bd8533d52178a2db5ff283d5c0", "parent_id": null, "name": "context_provider.process_request", "kind": "INTERNAL", "start_time": 1755776015861204300, "end_time": 1755776019181267100, "duration_ns": 3320062800, "status": {"status_code": "UNSET", "description": null}, "attributes": {"agent.method": "process_request", "agent.module": "src.agents.parallel.context_provider", "agent.type": "context_provider", "operation": "process_request", "agent.class": "ContextProviderAgent", "request.gamp_category": "4", "request.context_depth": "standard", "request.correlation_id": "f6a610d6-0c89-4f90-831b-09cb0f099827", "request.search_scope": "{}", "request.document_sections_count": 2, "request.timeout_seconds": 180, "request.test_types": "[]", "result.success": true, "result.documents_retrieved": 10, "result.context_quality": "low", "result.search_coverage": 0.0, "result.confidence_score": 0.4018861355180888, "result.processing_time": 3.318657}, "events": [{"name": "context_quality_assessment", "timestamp": 1755776019179733400, "attributes": {"avg_relevance": 0.4547153387952222, "section_coverage": 0.0, "required_sections": "[\"functional_requirements\", \"validation_requirements\"]", "covered_sections": "[\"2. Test Method Management\", \"3. Audit trail logging\", \"Understanding GAMP categories and their validation requirements\", \"GAMP Category 3: Non-configured systems test scripts\", \"1. User authentication required\", \"5. Integration Requirements\", \"3. Quality Control and Release\", \"Realistic OQ Test Scripts for Pharmaceutical Computerized Systems Validation\", \"1. Sample Management and Chain of Custody\", \"4. Regulatory Compliance Features\", \"2. Data integrity (ALCOA+ compliance)\", \"Environmental Monitoring System - Robust Scripted Format\", \"1. Navigate to sensor configuration screen\", \"4. Electronic signatures\"]", "quality": "low"}}, {"name": "confidence_calculation", "timestamp": 1755776019179876800, "attributes": {"avg_relevance": 0.4547153387952222, "search_coverage": 0.0, "context_quality": "low", "quality_factor": 0.6, "document_count": 10, "document_count_factor": 1.0, "final_confidence": 0.4018861355180888}}, {"name": "documents_retrieved", "timestamp": 1755776019179973300, "attributes": {"document_count": 10, "top_document_titles": "[\"Untitled Document\", \"Untitled Document\", \"Untitled Document\", \"Untitled Document\", \"Untitled Document\"]", "average_relevance_score": 0.4547153387952222}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:39.181326"}
{"span_id": "56df0dacb92f1009", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "194bb7e057247b60", "name": "fda.drug_labels_search", "kind": "INTERNAL", "start_time": 1755776019191690600, "end_time": 1755776020760048000, "duration_ns": 1568357400, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "drug_labels_search", "api.query": "computer software validation pharmaceutical", "api.limit": 3, "api.duration_seconds": 1.5683236122131348, "api.success": true, "api.results_count": 3}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:40.760144"}
{"span_id": "96a342c4a85b5576", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "194bb7e057247b60", "name": "fda.enforcement_search", "kind": "INTERNAL", "start_time": 1755776020761567200, "end_time": 1755776034553321100, "duration_ns": 13791753900, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "enforcement_search", "api.query": "computer software validation pharmaceutical", "api.limit": 2, "api.duration_seconds": 13.791879653930664, "api.success": true, "api.results_count": 2}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:33:54.553410"}
{"span_id": "f3f28e1e6ee2adb0", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "194bb7e057247b60", "name": "fda.drug_labels_search", "kind": "INTERNAL", "start_time": 1755776034554341400, "end_time": 1755776049707368800, "duration_ns": 15153027400, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "drug_labels_search", "api.query": "pharmaceutical Category 4", "api.limit": 3, "api.duration_seconds": 15.153132200241089, "api.success": true, "api.results_count": 3}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:09.707434"}
{"span_id": "7a94e4780b5ee521", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "194bb7e057247b60", "name": "fda.enforcement_search", "kind": "INTERNAL", "start_time": 1755776049708304300, "end_time": 1755776064538031700, "duration_ns": 14829727400, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "enforcement_search", "api.query": "pharmaceutical Category 4", "api.limit": 2, "api.duration_seconds": 14.829793691635132, "api.success": true, "api.results_count": 2}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:24.538107"}
{"span_id": "6f3fc448e5240a53", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "194bb7e057247b60", "name": "fda.drug_labels_search", "kind": "INTERNAL", "start_time": 1755776064538704800, "end_time": 1755776080379195400, "duration_ns": 15840490600, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "drug_labels_search", "api.query": "pharmaceutical OQ testing", "api.limit": 3, "api.duration_seconds": 15.840483903884888, "api.success": true, "api.results_count": 3}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:40.379297"}
{"span_id": "825c907057963c38", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "194bb7e057247b60", "name": "fda.enforcement_search", "kind": "INTERNAL", "start_time": 1755776080388940500, "end_time": 1755776094624729500, "duration_ns": 14235789000, "status": {"status_code": "UNSET", "description": null}, "attributes": {"api.service": "fda", "api.endpoint": "enforcement_search", "api.query": "pharmaceutical OQ testing", "api.limit": 2, "api.duration_seconds": 14.235873699188232, "api.success": true, "api.results_count": 2}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:54.624815"}
{"span_id": "194bb7e057247b60", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "586fcb4f9cb138b1", "name": "research.regulatory_updates", "kind": "INTERNAL", "start_time": 1755776019191656100, "end_time": 1755776094625812600, "duration_ns": 75434156500, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:54.625837"}
{"span_id": "299c1940c1535b05", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "586fcb4f9cb138b1", "name": "research.best_practices", "kind": "INTERNAL", "start_time": 1755776094626145700, "end_time": 1755776094626203000, "duration_ns": 57300, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:54.626221"}
{"span_id": "5f4c02fa0a9380ce", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "586fcb4f9cb138b1", "name": "research.industry_trends", "kind": "INTERNAL", "start_time": 1755776094626454100, "end_time": 1755776094626496700, "duration_ns": 42600, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:54.626513"}
{"span_id": "53df24af76e99747", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "586fcb4f9cb138b1", "name": "research.compile_results", "kind": "INTERNAL", "start_time": 1755776094626798000, "end_time": 1755776094626846400, "duration_ns": 48400, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:54.626862"}
{"span_id": "7df7bfe9611789ae", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "586fcb4f9cb138b1", "name": "research.generate_guidance", "kind": "INTERNAL", "start_time": 1755776094627085400, "end_time": 1755776094627133300, "duration_ns": 47900, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:54.627148"}
{"span_id": "962139d6289516c9", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "586fcb4f9cb138b1", "name": "research.analyze_compliance", "kind": "INTERNAL", "start_time": 1755776094627439600, "end_time": 1755776094630455800, "duration_ns": 3016200, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:54.630569"}
{"span_id": "586fcb4f9cb138b1", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": "ac817605e4c3e9f4", "name": "research.execute", "kind": "INTERNAL", "start_time": 1755776019191602700, "end_time": 1755776094631557100, "duration_ns": 75439954400, "status": {"status_code": "UNSET", "description": null}, "attributes": {"research.request_id": "ac6725fa-d53f-47fd-a5df-603d9d15358e", "research.depth_level": "comprehensive", "research.regulatory_updates_count": 6, "research.best_practices_count": 2, "research.industry_trends_count": 4, "research.total_results": 12, "research.guidance_summaries_count": 3, "research.quality": "low", "research.confidence_score": 0.6593333333333333, "research.strategy": "comprehensive_multi_source", "research.sources_count": 6}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:54.631647"}
{"span_id": "ac817605e4c3e9f4", "trace_id": "78abd63cc9d1167b25d973174affd597", "parent_id": null, "name": "research_agent.process_request", "kind": "INTERNAL", "start_time": 1755776019191399400, "end_time": 1755776094632329700, "duration_ns": 75440930300, "status": {"status_code": "UNSET", "description": null}, "attributes": {"agent.method": "process_request", "agent.module": "src.agents.parallel.research_agent", "agent.type": "research_agent", "operation": "process_request", "agent.class": "ResearchAgent", "request.correlation_id": "ac6725fa-d53f-47fd-a5df-603d9d15358e", "request.research_focus": "['GAMP-5', 'Category 4', 'OQ testing']", "request.regulatory_scope": "['FDA', 'EMA', 'ICH']", "request.depth_level": "comprehensive", "request.time_horizon": "current", "request.include_trends": true, "request.timeout_seconds": 240, "compliance.gamp5.research": true, "compliance.pharmaceutical": true, "result.results_count": 12, "result.regulatory_updates_count": 6, "result.best_practices_count": 2, "result.industry_trends_count": 4, "result.confidence_score": 0.6593333333333333, "result.research_quality": "low", "result.processing_time_seconds": 75.440524, "result.success": true}, "events": [{"name": "research_analysis_start", "timestamp": 1755776019191551300, "attributes": {"research_focus_count": 3, "regulatory_scope_count": 3, "depth_level": "comprehensive", "time_horizon": "current"}}, {"name": "research_analysis_complete", "timestamp": 1755776094632018900, "attributes": {"results_count": 12, "regulatory_updates_count": 6, "best_practices_count": 2, "confidence_score": 0.6593333333333333, "research_quality": "low", "processing_time": 75.440524}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:54.632380"}
{"span_id": "2c351e62d9c773b0", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "b812d09d8cf5b24d", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776094643680300, "end_time": 1755776097781953300, "duration_ns": 3138273000, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical validation expert specializing in GAMP Category 4, assess the compliance requirements for a system with the following characteristics:\\n        \\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - GAMP Category: unknown\\n        - Confidence Score: 0.0\\n        - Domain Knowledge Areas: \\n        - Validation Focus: enhanced\\n        \\n        Provide a comprehensive compliance assessment including:\\n        1. Applicable regulatory standards\\n        2. Compliance gaps that need attention\\n        3. Required controls for this GAMP category\\n        4. Certainty score (0.0-1.0) for this assessment\\n        \\n        Respond with valid JSON in this exact format:\\n        {\\n            \"level\": \"compliance_level\",\\n            \"applicable_standards\": [\"standard1\", \"standard2\"],\\n            \"compliance_gaps\": [{\"gap\": \"description\", \"impact\": \"high/medium/low\", \"recommendation\": \"action\"}],\\n            \"required_controls\": [\"control1\", \"control2\"],\\n            \"certainty_score\": 0.0\\n        }\\n        ',)", "input.value": "\n        As a pharmaceutical validation expert specializing in GAMP Category 4, assess the compliance requirements for a system with the following characteristics:\n        \n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - GAMP Category: unknown\n        - Confidence Score: 0.0\n        - Domain Knowledge Areas: \n        - Validation Focus: enhanced\n        \n        Provide a comprehensive compliance assessment including:\n        1. Applicable regulatory standards\n        2. Compliance gaps that need attention\n        3. Required controls for this GAMP category\n        4. Certainty score (0.0-1.0) for this assessment\n        \n        Respond with valid JSON in this exact format:\n        {\n            \"level\": \"compliance_level\",\n            \"applicable_standards\": [\"standard1\", \"standard2\"],\n            \"compliance_gaps\": [{\"gap\": \"description\", \"impact\": \"high/medium/low\", \"recommendation\": \"action\"}],\n            \"required_controls\": [\"control1\", \"control2\"],\n            \"certainty_score\": 0.0\n        }\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"level\": \"high\",\n    \"applicable_standards\": [\"FDA 21 CFR Part 11\", \"EU Annex 11\", \"ICH Q7\", \"GAMP 5\"],\n    \"compliance_gaps\": [\n        {\n            \"gap\": \"Unknown GAMP Category\",\n            \"impact\": \"high\",\n            \"recommendation\": \"Determine the GAMP Category based on system complexity and intended use.\"\n        },\n        {\n            \"gap\": \"Confidence Score of 0.0 indicates insufficient data for assessment\",\n            \"impact\": \"high\",\n            \"recommendation\": \"Gather additional system details and validation documentation to improve assessment accuracy.\"\n        },\n        {\n            \"gap\": \"Enhanced validation focus requires comprehensive testing\",\n            \"impact\": \"medium\",\n            \"recommendation\": \"Ensure OQ testing covers all critical functionalities and meets pharmaceutical compliance requirements.\"\n        }\n    ],\n    \"required_controls\": [\n        \"Risk Assessment and Management\",\n        \"Detailed Design and Functional Specifications\",\n        \"Comprehensive OQ Testing Protocol\",\n        \"Traceability Matrix\",\n        \"Change Control Procedures\",\n        \"Periodic Review and Revalidation\"\n    ],\n    \"certainty_score\": 0.0\n}", "llm.token_count.prompt": 280, "llm.token_count.completion": 298, "llm.token_count.total": 578, "llm.latency_ms": 3137.9077434539795}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:57.782078", "span_type": "llm", "prompt_tokens": 280, "completion_tokens": 298, "model": "deepseek/deepseek-chat"}
{"span_id": "b812d09d8cf5b24d", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "2595c0d7834130b8", "name": "sme.compliance_assessment", "kind": "INTERNAL", "start_time": 1755776094643475800, "end_time": 1755776097783439300, "duration_ns": 3139963500, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:34:57.783468"}
{"span_id": "254a2c8625903ec9", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "80bf308304b03d48", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776097784123200, "end_time": 1755776104244225900, "duration_ns": 6460102700, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical validation expert, analyze the validation risks for a system with these characteristics:\\n        \\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - Risk Factors: {}\\n        - Validation Focus: enhanced\\n        - GAMP Category: unknown\\n        \\n        Provide a comprehensive risk analysis including:\\n        1. Identified risks with categories, probability, and impact\\n        2. Overall risk level assessment\\n        3. Specific mitigation strategies\\n        4. Critical concerns requiring immediate attention\\n        5. Clarity score (0.0-1.0) for the risk assessment\\n        \\n        Consider pharmaceutical validation risks including:\\n        - Technical complexity and integration risks\\n        - Regulatory compliance gaps\\n        - Data integrity concerns (ALCOA+ principles)\\n        - Validation lifecycle risks\\n        - Change control and configuration management\\n        \\n        Respond with valid JSON in this exact format:\\n        {\\n            \"identified_risks\": [\\n                {\\n                    \"category\": \"category_name\",\\n                    \"risk\": \"risk_description\", \\n                    \"probability\": \"low/medium/high\",\\n                    \"impact\": \"low/medium/high/critical\",\\n                    \"mitigation\": \"mitigation_strategy\"\\n                }\\n            ],\\n            \"risk_level\": \"critical/high/medium/low\",\\n            \"mitigation_strategies\": [\\n                {\\n                    \"strategy\": \"strategy_description\",\\n                    \"priority\": \"critical/high/medium/low\", \\n                    \"timeline\": \"immediate/planned/future\"\\n                }\\n            ],\\n            \"critical_concerns\": [\"concern1\", \"concern2\"],\\n            \"clarity_score\": 0.0\\n        }\\n        ',)", "input.value": "\n        As a pharmaceutical validation expert, analyze the validation risks for a system with these characteristics:\n        \n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - Risk Factors: {}\n        - Validation Focus: enhanced\n        - GAMP Category: unknown\n        \n        Provide a comprehensive risk analysis including:\n        1. Identified risks with categories, probability, and impact\n        2. Overall risk level assessment\n        3. Specific mitigation strategies\n        4. Critical concerns requiring immediate attention\n        5. Clarity score (0.0-1.0) for the risk assessment\n        \n        Consider pharmaceutical validation risks including:\n        - Technical complexity and integration risks\n        - Regulatory compliance gaps\n        - Data integrity concerns (ALCOA+ principles)\n        - Validation lifecycle risks\n        - Change control and configuration management\n        \n        Respond with valid JSON in this exact format:\n        {\n            \"identified_risks\": [\n                {\n                    \"category\": \"category_name\",\n                    \"risk\": \"risk_description\", \n                    \"probability\": \"low/medium/high\",\n                    \"impact\": \"low/medium/high/critical\",\n                    \"mitigation\": \"mitigation_strategy\"\n                }\n            ],\n            \"risk_level\": \"critical/high/medium/low\",\n            \"mitigation_strategies\": [\n                {\n                    \"strategy\": \"strategy_description\",\n                    \"priority\": \"critical/high/medium/low\", \n                    \"timeline\": \"immediate/planned/future\"\n                }\n            ],\n            \"critical_concerns\": [\"concern1\", \"concern2\"],\n            \"clarity_score\": 0.0\n        }\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"identified_risks\": [\n        {\n            \"category\": \"Regulatory Compliance\",\n            \"risk\": \"Potential gaps in meeting high compliance requirements due to unknown GAMP category\",\n            \"probability\": \"medium\",\n            \"impact\": \"critical\",\n            \"mitigation\": \"Conduct a detailed GAMP category assessment and align validation activities with regulatory expectations\"\n        },\n        {\n            \"category\": \"Technical Complexity\",\n            \"risk\": \"Integration risks due to system complexity and lack of defined risk factors\",\n            \"probability\": \"high\",\n            \"impact\": \"high\",\n            \"mitigation\": \"Perform a thorough technical risk assessment and develop a robust integration testing plan\"\n        },\n        {\n            \"category\": \"Data Integrity\",\n            \"risk\": \"Potential non-compliance with ALCOA+ principles due to insufficient focus on data integrity\",\n            \"probability\": \"medium\",\n            \"impact\": \"critical\",\n            \"mitigation\": \"Implement data integrity checks and validation protocols aligned with ALCOA+ principles\"\n        },\n        {\n            \"category\": \"Validation Lifecycle\",\n            \"risk\": \"Incomplete validation lifecycle due to enhanced focus without clear scope\",\n            \"probability\": \"medium\",\n            \"impact\": \"high\",\n            \"mitigation\": \"Define a clear validation lifecycle scope and ensure all phases are adequately addressed\"\n        },\n        {\n            \"category\": \"Change Control\",\n            \"risk\": \"Inadequate change control processes leading to configuration management issues\",\n            \"probability\": \"low\",\n            \"impact\": \"medium\",\n            \"mitigation\": \"Establish a robust change control process and ensure proper documentation of configuration changes\"\n        }\n    ],\n    \"risk_level\": \"high\",\n    \"mitigation_strategies\": [\n        {\n            \"strategy\": \"Conduct a GAMP category assessment to clarify system classification\",\n            \"priority\": \"critical\",\n            \"timeline\": \"immediate\"\n        },\n        {\n            \"strategy\": \"Develop and execute a comprehensive technical risk assessment plan\",\n            \"priority\": \"high\",\n            \"timeline\": \"planned\"\n        },\n        {\n            \"strategy\": \"Implement data integrity protocols aligned with ALCOA+ principles\",\n            \"priority\": \"critical\",\n            \"timeline\": \"immediate\"\n        },\n        {\n            \"strategy\": \"Define and document the validation lifecycle scope\",\n            \"priority\": \"high\",\n            \"timeline\": \"planned\"\n        },\n        {\n            \"strategy\": \"Establish a robust change control process\",\n            \"priority\": \"medium\",\n            \"timeline\": \"future\"\n        }\n    ],\n    \"critical_concerns\": [\n        \"Unknown GAMP category leading to regulatory compliance gaps\",\n        \"Potential non-compliance with ALCOA+ principles\"\n    ],\n    \"clarity_score\": 0.7\n}", "llm.token_count.prompt": 462, "llm.token_count.completion": 742, "llm.token_count.total": 1204, "llm.latency_ms": 6459.803581237793}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:04.244358", "span_type": "llm", "prompt_tokens": 462, "completion_tokens": 742, "model": "deepseek/deepseek-chat"}
{"span_id": "80bf308304b03d48", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "2595c0d7834130b8", "name": "sme.risk_analysis", "kind": "INTERNAL", "start_time": 1755776097783838500, "end_time": 1755776104246393800, "duration_ns": 6462555300, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:04.246485"}
{"span_id": "4fd76553b98523b2", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "75df3d9aceb3d069", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776104247719200, "end_time": 1755776113968547200, "duration_ns": 9720828000, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical validation expert specializing in GAMP Category 4, generate specific recommendations based on this analysis:\\n        \\n        COMPLIANCE ASSESSMENT:\\n        {\\'level\\': \\'high\\', \\'applicable_standards\\': [\\'FDA 21 CFR Part 11\\', \\'EU Annex 11\\', \\'ICH Q7\\', \\'GAMP 5\\'], \\'compliance_gaps\\': [{\\'gap\\': \\'Unknown GAMP Category\\', \\'impact\\': \\'high\\', \\'recommendation\\': \\'Determine the GAMP Category based on system complexity and intended use.\\'}, {\\'gap\\': \\'Confidence Score of 0.0 indicates insufficient data for assessment\\', \\'impact\\': \\'high\\', \\'recommendation\\': \\'Gather additional system details and validation documentation to improve assessment accuracy.\\'}, {\\'gap\\': \\'Enhanced validation focus requires comprehensive testing\\', \\'impact\\': \\'medium\\', \\'recommendation\\': \\'Ensure OQ testing covers all critical functionalities and meets pharmaceutical compliance requirements.\\'}], \\'required_controls\\': [\\'Risk Assessment and Management\\', \\'Detailed Design and Functional Specifications\\', \\'Comprehensive OQ Testing Protocol\\', \\'Traceability Matrix\\', \\'Change Control Procedures\\', \\'Periodic Review and Revalidation\\'], \\'certainty_score\\': 0.0}\\n        \\n        RISK ANALYSIS:\\n        {\\'identified_risks\\': [{\\'category\\': \\'Regulatory Compliance\\', \\'risk\\': \\'Potential gaps in meeting high compliance requirements due to unknown GAMP category\\', \\'probability\\': \\'medium\\', \\'impact\\': \\'critical\\', \\'mitigation\\': \\'Conduct a detailed GAMP category assessment and align validation activities with regulatory expectations\\'}, {\\'category\\': \\'Technical Complexity\\', \\'risk\\': \\'Integration risks due to system complexity and lack of defined risk factors\\', \\'probability\\': \\'high\\', \\'impact\\': \\'high\\', \\'mitigation\\': \\'Perform a thorough technical risk assessment and develop a robust integration testing plan\\'}, {\\'category\\': \\'Data Integrity\\', \\'risk\\': \\'Potential non-compliance with ALCOA+ principles due to insufficient focus on data integrity\\', \\'probability\\': \\'medium\\', \\'impact\\': \\'critical\\', \\'mitigation\\': \\'Implement data integrity checks and validation protocols aligned with ALCOA+ principles\\'}, {\\'category\\': \\'Validation Lifecycle\\', \\'risk\\': \\'Incomplete validation lifecycle due to enhanced focus without clear scope\\', \\'probability\\': \\'medium\\', \\'impact\\': \\'high\\', \\'mitigation\\': \\'Define a clear validation lifecycle scope and ensure all phases are adequately addressed\\'}, {\\'category\\': \\'Change Control\\', \\'risk\\': \\'Inadequate change control processes leading to configuration management issues\\', \\'probability\\': \\'low\\', \\'impact\\': \\'medium\\', \\'mitigation\\': \\'Establish a robust change control process and ensure proper documentation of configuration changes\\'}], \\'risk_level\\': \\'high\\', \\'mitigation_strategies\\': [{\\'strategy\\': \\'Conduct a GAMP category assessment to clarify system classification\\', \\'priority\\': \\'critical\\', \\'timeline\\': \\'immediate\\'}, {\\'strategy\\': \\'Develop and execute a comprehensive technical risk assessment plan\\', \\'priority\\': \\'high\\', \\'timeline\\': \\'planned\\'}, {\\'strategy\\': \\'Implement data integrity protocols aligned with ALCOA+ principles\\', \\'priority\\': \\'critical\\', \\'timeline\\': \\'immediate\\'}, {\\'strategy\\': \\'Define and document the validation lifecycle scope\\', \\'priority\\': \\'high\\', \\'timeline\\': \\'planned\\'}, {\\'strategy\\': \\'Establish a robust change control process\\', \\'priority\\': \\'medium\\', \\'timeline\\': \\'future\\'}], \\'critical_concerns\\': [\\'Unknown GAMP category leading to regulatory compliance gaps\\', \\'Potential non-compliance with ALCOA+ principles\\'], \\'clarity_score\\': 0.7}\\n        \\n        SYSTEM CONTEXT:\\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - GAMP Category: unknown\\n        \\n        Generate up to 10 prioritized recommendations that address:\\n        1. Compliance gaps identified in the assessment\\n        2. Risk mitigation strategies\\n        3. Domain-specific best practices for GAMP Category 4\\n        4. Validation approach recommendations\\n        5. Implementation guidance\\n        \\n        Each recommendation must include:\\n        - Specific, actionable recommendation\\n        - Clear rationale tied to compliance/risk analysis\\n        - Priority level (high/medium/low)\\n        - Implementation effort estimate\\n        - Expected benefit category\\n        \\n        Respond with valid JSON in this exact format:\\n        [\\n            {\\n                \"category\": \"category_name\",\\n                \"priority\": \"critical/high/medium/low\",\\n                \"recommendation\": \"specific_actionable_recommendation\",\\n                \"rationale\": \"clear_justification\",\\n                \"implementation_effort\": \"high/medium/low\",\\n                \"expected_benefit\": \"benefit_category\"\\n            }\\n        ]\\n        ',)", "input.value": "\n        As a pharmaceutical validation expert specializing in GAMP Category 4, generate specific recommendations based on this analysis:\n        \n        COMPLIANCE ASSESSMENT:\n        {'level': 'high', 'applicable_standards': ['FDA 21 CFR Part 11', 'EU Annex 11', 'ICH Q7', 'GAMP 5'], 'compliance_gaps': [{'gap': 'Unknown GAMP Category', 'impact': 'high', 'recommendation': 'Determine the GAMP Category based on system complexity and intended use.'}, {'gap': 'Confidence Score of 0.0 indicates insufficient data for assessment', 'impact': 'high', 'recommendation': 'Gather additional system details and validation documentation to improve assessment accuracy.'}, {'gap': 'Enhanced validation focus requires comprehensive testing', 'impact': 'medium', 'recommendation': 'Ensure OQ testing covers all critical functionalities and meets pharmaceutical compliance requirements.'}], 'required_controls': ['Risk Assessment and Management', 'Detailed Design and Functional Specifications', 'Comprehensive OQ Testing Protocol', 'Traceability Matrix', 'Change Control Procedures', 'Periodic Review and Revalidation'], 'certainty_score': 0.0}\n        \n        RISK ANALYSIS:\n        {'identified_risks': [{'category': 'Regulatory Compliance', 'risk': 'Potential gaps in meeting high compliance requirements due to unknown GAMP category', 'probability': 'medium', 'impact': 'critical', 'mitigation': 'Conduct a detailed GAMP category assessment and align validation activities with regulatory expectations'}, {'category': 'Technical Complexity', 'risk': 'Integration risks due to system complexity and lack of defined risk factors', 'probability': 'high', 'impact': 'high', 'mitigation': 'Perform a thorough technical risk assessment and develop a robust integration testing plan'}, {'category': 'Data Integrity', 'risk': 'Potential non-compliance with ALCOA+ principles due to insufficient focus on data integrity', 'probability': 'medium', 'impact': 'critical', 'mitigation': 'Implement data integrity checks and validation protocols aligned with ALCOA+ principles'}, {'category': 'Validation Lifecycle', 'risk': 'Incomplete validation lifecycle due to enhanced focus without clear scope', 'probability': 'medium', 'impact': 'high', 'mitigation': 'Define a clear validation lifecycle scope and ensure all phases are adequately addressed'}, {'category': 'Change Control', 'risk': 'Inadequate change control processes leading to configuration management issues', 'probability': 'low', 'impact': 'medium', 'mitigation': 'Establish a robust change control process and ensure proper documentation of configuration changes'}], 'risk_level': 'high', 'mitigation_strategies': [{'strategy': 'Conduct a GAMP category assessment to clarify system classification', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Develop and execute a comprehensive technical risk assessment plan', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Implement data integrity protocols aligned with ALCOA+ principles', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Define and document the validation lifecycle scope', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Establish a robust change control process', 'priority': 'medium', 'timeline': 'future'}], 'critical_concerns': ['Unknown GAMP category leading to regulatory compliance gaps', 'Potential non-compliance with ALCOA+ principles'], 'clarity_score': 0.7}\n        \n        SYSTEM CONTEXT:\n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - GAMP Category: unknown\n        \n        Generate up to 10 prioritized recommendations that address:\n        1. Compliance gaps identified in the assessment\n        2. Risk mitigation strategies\n        3. Domain-specific best practices for GAMP Category 4\n        4. Validation approach recommendations\n        5. Implementation guidance\n        \n        Each recommendation must include:\n        - Specific, actionable recommendation\n        - Clear rationale tied to compliance/risk analysis\n        - Priority level (high/medium/low)\n        - Implementation effort estimate\n        - Expected benefit category\n        \n        Respond with valid JSON in this exact format:\n        [\n            {\n                \"category\": \"category_name\",\n                \"priority\": \"critical/high/medium/low\",\n                \"recommendation\": \"specific_actionable_recommendation\",\n                \"rationale\": \"clear_justification\",\n                \"implementation_effort\": \"high/medium/low\",\n                \"expected_benefit\": \"benefit_category\"\n            }\n        ]\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "[\n    {\n        \"category\": \"Compliance\",\n        \"priority\": \"critical\",\n        \"recommendation\": \"Conduct a detailed GAMP category assessment to classify the system as GAMP Category 4 based on its complexity and intended use.\",\n        \"rationale\": \"Unknown GAMP category poses a high risk of regulatory non-compliance. Clarifying the category ensures alignment with FDA 21 CFR Part 11, EU Annex 11, and GAMP 5 standards.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"Regulatory Compliance\"\n    },\n    {\n        \"category\": \"Risk Mitigation\",\n        \"priority\": \"critical\",\n        \"recommendation\": \"Implement data integrity protocols aligned with ALCOA+ principles to ensure compliance with pharmaceutical standards.\",\n        \"rationale\": \"Insufficient focus on data integrity risks non-compliance with ALCOA+ principles, which is critical for pharmaceutical systems.\",\n        \"implementation_effort\": \"high\",\n        \"expected_benefit\": \"Data Integrity\"\n    },\n    {\n        \"category\": \"Validation\",\n        \"priority\": \"high\",\n        \"recommendation\": \"Develop a comprehensive OQ testing protocol covering all critical functionalities to meet pharmaceutical compliance requirements.\",\n        \"rationale\": \"Enhanced validation focus requires thorough testing to ensure system functionality aligns with regulatory expectations.\",\n        \"implementation_effort\": \"high\",\n        \"expected_benefit\": \"Validation Accuracy\"\n    },\n    {\n        \"category\": \"Risk Mitigation\",\n        \"priority\": \"high\",\n        \"recommendation\": \"Perform a technical risk assessment to identify integration risks and develop a robust testing plan.\",\n        \"rationale\": \"High technical complexity and undefined risk factors increase the likelihood of integration failures.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"System Reliability\"\n    },\n    {\n        \"category\": \"Compliance\",\n        \"priority\": \"high\",\n        \"recommendation\": \"Establish a traceability matrix to ensure all requirements are linked to test cases and validation activities.\",\n        \"rationale\": \"Traceability ensures accountability and completeness in meeting regulatory and functional requirements.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"Regulatory Compliance\"\n    },\n    {\n        \"category\": \"Validation\",\n        \"priority\": \"medium\",\n        \"recommendation\": \"Define and document the validation lifecycle scope to ensure all phases are adequately addressed.\",\n        \"rationale\": \"Incomplete validation lifecycle increases the risk of gaps in system validation and compliance.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"Validation Completeness\"\n    },\n    {\n        \"category\": \"Risk Mitigation\",\n        \"priority\": \"medium\",\n        \"recommendation\": \"Establish a robust change control process to manage configuration changes effectively.\",\n        \"rationale\": \"Inadequate change control processes can lead to configuration management issues and compliance gaps.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"System Stability\"\n    },\n    {\n        \"category\": \"Compliance\",\n        \"priority\": \"medium\",\n        \"recommendation\": \"Conduct periodic reviews and revalidation to ensure ongoing compliance with regulatory standards.\",\n        \"rationale\": \"Periodic reviews mitigate the risk of non-compliance due to system changes or evolving regulations.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"Regulatory Compliance\"\n    },\n    {\n        \"category\": \"Best Practices\",\n        \"priority\": \"medium\",\n        \"recommendation\": \"Develop detailed design and functional specifications to guide system development and validation.\",\n        \"rationale\": \"Clear specifications reduce ambiguity and ensure alignment with GAMP Category 4 requirements.\",\n        \"implementation_effort\": \"medium\",\n        \"expected_benefit\": \"System Clarity\"\n    },\n    {\n        \"category\": \"Risk Mitigation\",\n        \"priority\": \"low\",\n        \"recommendation\": \"Train staff on GAMP Category 4 requirements and validation best practices to enhance compliance awareness.\",\n        \"rationale\": \"Improved knowledge reduces the risk of errors and ensures adherence to regulatory standards.\",\n        \"implementation_effort\": \"low\",\n        \"expected_benefit\": \"Compliance Awareness\"\n    }\n]", "llm.token_count.prompt": 1169, "llm.token_count.completion": 1106, "llm.token_count.total": 2275, "llm.latency_ms": 9720.547437667847}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:13.968696", "span_type": "llm", "prompt_tokens": 1169, "completion_tokens": 1106, "model": "deepseek/deepseek-chat"}
{"span_id": "75df3d9aceb3d069", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "2595c0d7834130b8", "name": "sme.generate_recommendations", "kind": "INTERNAL", "start_time": 1755776104247217300, "end_time": 1755776113970533000, "duration_ns": 9723315700, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:13.970570"}
{"span_id": "33d6dcc5e81007b8", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "71f851f7b2b965a6", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776113971370500, "end_time": 1755776120696138900, "duration_ns": 6724768400, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical validation expert specializing in GAMP Category 4, provide specific validation guidance based on:\\n        \\n        CONTEXT:\\n        - Specialty: GAMP Category 4\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - Compliance Level: high\\n        - GAMP Category: unknown\\n        - Validation Focus Areas: enhanced\\n        \\n        RECOMMENDATIONS TO IMPLEMENT:\\n        [{\\'category\\': \\'Compliance\\', \\'priority\\': \\'critical\\', \\'recommendation\\': \\'Conduct a detailed GAMP category assessment to classify the system as GAMP Category 4 based on its complexity and intended use.\\', \\'rationale\\': \\'Unknown GAMP category poses a high risk of regulatory non-compliance. Clarifying the category ensures alignment with FDA 21 CFR Part 11, EU Annex 11, and GAMP 5 standards.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'Regulatory Compliance\\'}, {\\'category\\': \\'Risk Mitigation\\', \\'priority\\': \\'critical\\', \\'recommendation\\': \\'Implement data integrity protocols aligned with ALCOA+ principles to ensure compliance with pharmaceutical standards.\\', \\'rationale\\': \\'Insufficient focus on data integrity risks non-compliance with ALCOA+ principles, which is critical for pharmaceutical systems.\\', \\'implementation_effort\\': \\'high\\', \\'expected_benefit\\': \\'Data Integrity\\'}, {\\'category\\': \\'Validation\\', \\'priority\\': \\'high\\', \\'recommendation\\': \\'Develop a comprehensive OQ testing protocol covering all critical functionalities to meet pharmaceutical compliance requirements.\\', \\'rationale\\': \\'Enhanced validation focus requires thorough testing to ensure system functionality aligns with regulatory expectations.\\', \\'implementation_effort\\': \\'high\\', \\'expected_benefit\\': \\'Validation Accuracy\\'}, {\\'category\\': \\'Risk Mitigation\\', \\'priority\\': \\'high\\', \\'recommendation\\': \\'Perform a technical risk assessment to identify integration risks and develop a robust testing plan.\\', \\'rationale\\': \\'High technical complexity and undefined risk factors increase the likelihood of integration failures.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'System Reliability\\'}, {\\'category\\': \\'Compliance\\', \\'priority\\': \\'high\\', \\'recommendation\\': \\'Establish a traceability matrix to ensure all requirements are linked to test cases and validation activities.\\', \\'rationale\\': \\'Traceability ensures accountability and completeness in meeting regulatory and functional requirements.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'Regulatory Compliance\\'}, {\\'category\\': \\'Validation\\', \\'priority\\': \\'medium\\', \\'recommendation\\': \\'Define and document the validation lifecycle scope to ensure all phases are adequately addressed.\\', \\'rationale\\': \\'Incomplete validation lifecycle increases the risk of gaps in system validation and compliance.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'Validation Completeness\\'}, {\\'category\\': \\'Risk Mitigation\\', \\'priority\\': \\'medium\\', \\'recommendation\\': \\'Establish a robust change control process to manage configuration changes effectively.\\', \\'rationale\\': \\'Inadequate change control processes can lead to configuration management issues and compliance gaps.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'System Stability\\'}, {\\'category\\': \\'Compliance\\', \\'priority\\': \\'medium\\', \\'recommendation\\': \\'Conduct periodic reviews and revalidation to ensure ongoing compliance with regulatory standards.\\', \\'rationale\\': \\'Periodic reviews mitigate the risk of non-compliance due to system changes or evolving regulations.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'Regulatory Compliance\\'}, {\\'category\\': \\'Best Practices\\', \\'priority\\': \\'medium\\', \\'recommendation\\': \\'Develop detailed design and functional specifications to guide system development and validation.\\', \\'rationale\\': \\'Clear specifications reduce ambiguity and ensure alignment with GAMP Category 4 requirements.\\', \\'implementation_effort\\': \\'medium\\', \\'expected_benefit\\': \\'System Clarity\\'}, {\\'category\\': \\'Risk Mitigation\\', \\'priority\\': \\'low\\', \\'recommendation\\': \\'Train staff on GAMP Category 4 requirements and validation best practices to enhance compliance awareness.\\', \\'rationale\\': \\'Improved knowledge reduces the risk of errors and ensures adherence to regulatory standards.\\', \\'implementation_effort\\': \\'low\\', \\'expected_benefit\\': \\'Compliance Awareness\\'}]\\n        \\n        Provide specific, actionable validation guidance covering:\\n        1. Test strategy approach tailored to the test focus\\n        2. Compliance validation procedures for the compliance level\\n        3. Risk management guidance based on recommendations\\n        4. Domain-specific validation approaches\\n        5. Quality assurance considerations\\n        \\n        Each guidance item should include:\\n        - Area of focus\\n        - Specific guidance instructions\\n        - Key considerations/checkpoints\\n        - Clear success criteria\\n        \\n        Respond with valid JSON in this exact format:\\n        [\\n            {\\n                \"area\": \"area_name\",\\n                \"guidance\": \"specific_guidance_instructions\",\\n                \"key_considerations\": [\"consideration1\", \"consideration2\"],\\n                \"success_criteria\": \"clear_success_criteria\"\\n            }\\n        ]\\n        ',)", "input.value": "\n        As a pharmaceutical validation expert specializing in GAMP Category 4, provide specific validation guidance based on:\n        \n        CONTEXT:\n        - Specialty: GAMP Category 4\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - Compliance Level: high\n        - GAMP Category: unknown\n        - Validation Focus Areas: enhanced\n        \n        RECOMMENDATIONS TO IMPLEMENT:\n        [{'category': 'Compliance', 'priority': 'critical', 'recommendation': 'Conduct a detailed GAMP category assessment to classify the system as GAMP Category 4 based on its complexity and intended use.', 'rationale': 'Unknown GAMP category poses a high risk of regulatory non-compliance. Clarifying the category ensures alignment with FDA 21 CFR Part 11, EU Annex 11, and GAMP 5 standards.', 'implementation_effort': 'medium', 'expected_benefit': 'Regulatory Compliance'}, {'category': 'Risk Mitigation', 'priority': 'critical', 'recommendation': 'Implement data integrity protocols aligned with ALCOA+ principles to ensure compliance with pharmaceutical standards.', 'rationale': 'Insufficient focus on data integrity risks non-compliance with ALCOA+ principles, which is critical for pharmaceutical systems.', 'implementation_effort': 'high', 'expected_benefit': 'Data Integrity'}, {'category': 'Validation', 'priority': 'high', 'recommendation': 'Develop a comprehensive OQ testing protocol covering all critical functionalities to meet pharmaceutical compliance requirements.', 'rationale': 'Enhanced validation focus requires thorough testing to ensure system functionality aligns with regulatory expectations.', 'implementation_effort': 'high', 'expected_benefit': 'Validation Accuracy'}, {'category': 'Risk Mitigation', 'priority': 'high', 'recommendation': 'Perform a technical risk assessment to identify integration risks and develop a robust testing plan.', 'rationale': 'High technical complexity and undefined risk factors increase the likelihood of integration failures.', 'implementation_effort': 'medium', 'expected_benefit': 'System Reliability'}, {'category': 'Compliance', 'priority': 'high', 'recommendation': 'Establish a traceability matrix to ensure all requirements are linked to test cases and validation activities.', 'rationale': 'Traceability ensures accountability and completeness in meeting regulatory and functional requirements.', 'implementation_effort': 'medium', 'expected_benefit': 'Regulatory Compliance'}, {'category': 'Validation', 'priority': 'medium', 'recommendation': 'Define and document the validation lifecycle scope to ensure all phases are adequately addressed.', 'rationale': 'Incomplete validation lifecycle increases the risk of gaps in system validation and compliance.', 'implementation_effort': 'medium', 'expected_benefit': 'Validation Completeness'}, {'category': 'Risk Mitigation', 'priority': 'medium', 'recommendation': 'Establish a robust change control process to manage configuration changes effectively.', 'rationale': 'Inadequate change control processes can lead to configuration management issues and compliance gaps.', 'implementation_effort': 'medium', 'expected_benefit': 'System Stability'}, {'category': 'Compliance', 'priority': 'medium', 'recommendation': 'Conduct periodic reviews and revalidation to ensure ongoing compliance with regulatory standards.', 'rationale': 'Periodic reviews mitigate the risk of non-compliance due to system changes or evolving regulations.', 'implementation_effort': 'medium', 'expected_benefit': 'Regulatory Compliance'}, {'category': 'Best Practices', 'priority': 'medium', 'recommendation': 'Develop detailed design and functional specifications to guide system development and validation.', 'rationale': 'Clear specifications reduce ambiguity and ensure alignment with GAMP Category 4 requirements.', 'implementation_effort': 'medium', 'expected_benefit': 'System Clarity'}, {'category': 'Risk Mitigation', 'priority': 'low', 'recommendation': 'Train staff on GAMP Category 4 requirements and validation best practices to enhance compliance awareness.', 'rationale': 'Improved knowledge reduces the risk of errors and ensures adherence to regulatory standards.', 'implementation_effort': 'low', 'expected_benefit': 'Compliance Awareness'}]\n        \n        Provide specific, actionable validation guidance covering:\n        1. Test strategy approach tailored to the test focus\n        2. Compliance validation procedures for the compliance level\n        3. Risk management guidance based on recommendations\n        4. Domain-specific validation approaches\n        5. Quality assurance considerations\n        \n        Each guidance item should include:\n        - Area of focus\n        - Specific guidance instructions\n        - Key considerations/checkpoints\n        - Clear success criteria\n        \n        Respond with valid JSON in this exact format:\n        [\n            {\n                \"area\": \"area_name\",\n                \"guidance\": \"specific_guidance_instructions\",\n                \"key_considerations\": [\"consideration1\", \"consideration2\"],\n                \"success_criteria\": \"clear_success_criteria\"\n            }\n        ]\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "```json\n[\n    {\n        \"area\": \"Test Strategy\",\n        \"guidance\": \"Develop a risk-based OQ testing strategy focusing on critical functionalities of the GAMP Category 4 system. Prioritize testing scenarios that ensure system performance under operational conditions.\",\n        \"key_considerations\": [\"Identify critical functionalities\", \"Ensure coverage of operational scenarios\", \"Align with pharmaceutical compliance requirements\"],\n        \"success_criteria\": \"All critical functionalities are tested, and results meet predefined acceptance criteria.\"\n    },\n    {\n        \"area\": \"Compliance Validation\",\n        \"guidance\": \"Implement a traceability matrix to link system requirements to test cases and validation activities. Conduct periodic reviews to ensure ongoing compliance with FDA 21 CFR Part 11 and EU Annex 11.\",\n        \"key_considerations\": [\"Ensure traceability of requirements\", \"Conduct periodic compliance reviews\", \"Document validation activities\"],\n        \"success_criteria\": \"All requirements are traceable to test cases, and periodic reviews confirm compliance.\"\n    },\n    {\n        \"area\": \"Risk Management\",\n        \"guidance\": \"Perform a technical risk assessment to identify integration risks. Develop a robust testing plan to mitigate identified risks and ensure system reliability.\",\n        \"key_considerations\": [\"Identify integration risks\", \"Develop risk mitigation strategies\", \"Implement a robust testing plan\"],\n        \"success_criteria\": \"Integration risks are mitigated, and system reliability is confirmed through testing.\"\n    },\n    {\n        \"area\": \"Domain-Specific Validation\",\n        \"guidance\": \"Define and document the validation lifecycle scope for the GAMP Category 4 system. Ensure all phases, including design, development, and testing, are adequately addressed.\",\n        \"key_considerations\": [\"Define validation lifecycle scope\", \"Document all validation phases\", \"Ensure alignment with GAMP Category 4 requirements\"],\n        \"success_criteria\": \"Validation lifecycle is fully documented, and all phases are completed successfully.\"\n    },\n    {\n        \"area\": \"Quality Assurance\",\n        \"guidance\": \"Establish a robust change control process to manage configuration changes effectively. Train staff on GAMP Category 4 requirements and validation best practices.\",\n        \"key_considerations\": [\"Implement change control processes\", \"Train staff on validation best practices\", \"Ensure adherence to GAMP Category 4 requirements\"],\n        \"success_criteria\": \"Configuration changes are managed effectively, and staff demonstrate compliance awareness.\"\n    }\n]\n```", "llm.token_count.prompt": 1292, "llm.token_count.completion": 657, "llm.token_count.total": 1949, "llm.latency_ms": 6724.515676498413}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:20.696279", "span_type": "llm", "prompt_tokens": 1292, "completion_tokens": 657, "model": "deepseek/deepseek-chat"}
{"span_id": "71f851f7b2b965a6", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "2595c0d7834130b8", "name": "sme.validation_guidance", "kind": "INTERNAL", "start_time": 1755776113970982700, "end_time": 1755776120697731600, "duration_ns": 6726748900, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:20.697765"}
{"span_id": "8de67fa16266726d", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "6e41f57a6de8118c", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776120698431800, "end_time": 1755776124938349300, "duration_ns": 4239917500, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical validation expert specializing in GAMP Category 4, provide domain-specific insights for a validation project with these characteristics:\\n        \\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - Domain Knowledge Areas: \\n        - GAMP Category: unknown\\n        \\n        Provide comprehensive domain insights including:\\n        1. Current industry trends affecting GAMP Category 4\\n        2. Best practices specific to this specialty and compliance level\\n        3. Common pitfalls to avoid in GAMP Category 4 projects\\n        4. Key expertise areas that are critical for success\\n        5. Emerging challenges and opportunities\\n        \\n        Focus on practical, actionable insights that can improve validation outcomes.\\n        \\n        Respond with valid JSON in this exact format:\\n        {\\n            \"specialty_focus\": \"specialty_name\",\\n            \"key_expertise_areas\": [\"area1\", \"area2\"],\\n            \"industry_trends\": [\"trend1\", \"trend2\"],\\n            \"best_practices\": [\"practice1\", \"practice2\"],\\n            \"common_pitfalls\": [\"pitfall1\", \"pitfall2\"],\\n            \"emerging_challenges\": [\"challenge1\", \"challenge2\"],\\n            \"opportunities\": [\"opportunity1\", \"opportunity2\"]\\n        }\\n        ',)", "input.value": "\n        As a pharmaceutical validation expert specializing in GAMP Category 4, provide domain-specific insights for a validation project with these characteristics:\n        \n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - Domain Knowledge Areas: \n        - GAMP Category: unknown\n        \n        Provide comprehensive domain insights including:\n        1. Current industry trends affecting GAMP Category 4\n        2. Best practices specific to this specialty and compliance level\n        3. Common pitfalls to avoid in GAMP Category 4 projects\n        4. Key expertise areas that are critical for success\n        5. Emerging challenges and opportunities\n        \n        Focus on practical, actionable insights that can improve validation outcomes.\n        \n        Respond with valid JSON in this exact format:\n        {\n            \"specialty_focus\": \"specialty_name\",\n            \"key_expertise_areas\": [\"area1\", \"area2\"],\n            \"industry_trends\": [\"trend1\", \"trend2\"],\n            \"best_practices\": [\"practice1\", \"practice2\"],\n            \"common_pitfalls\": [\"pitfall1\", \"pitfall2\"],\n            \"emerging_challenges\": [\"challenge1\", \"challenge2\"],\n            \"opportunities\": [\"opportunity1\", \"opportunity2\"]\n        }\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"specialty_focus\": \"GAMP Category 4\",\n    \"key_expertise_areas\": [\"system integration\", \"risk management\", \"regulatory compliance\", \"test case design\", \"documentation standards\"],\n    \"industry_trends\": [\"increased adoption of digital validation tools\", \"focus on data integrity and ALCOA+ principles\", \"shift towards continuous validation and lifecycle management\", \"integration of AI/ML in validation processes\"],\n    \"best_practices\": [\"conduct thorough risk assessments early in the project\", \"ensure clear traceability between requirements and test cases\", \"leverage modular testing approaches for efficiency\", \"maintain rigorous documentation aligned with regulatory standards\", \"collaborate closely with stakeholders to align expectations\"],\n    \"common_pitfalls\": [\"inadequate risk assessment leading to gaps in testing\", \"poor documentation practices causing audit failures\", \"overlooking system integration complexities\", \"insufficient training for end-users and testers\", \"failure to align validation with evolving regulatory requirements\"],\n    \"emerging_challenges\": [\"managing validation for increasingly complex systems\", \"ensuring compliance with evolving global regulations\", \"balancing speed and thoroughness in validation processes\", \"integrating legacy systems with modern technologies\"],\n    \"opportunities\": [\"leveraging automation to streamline validation processes\", \"adopting advanced analytics for predictive validation insights\", \"enhancing collaboration through digital platforms\", \"developing standardized validation frameworks for scalability\"]\n}", "llm.token_count.prompt": 334, "llm.token_count.completion": 395, "llm.token_count.total": 729, "llm.latency_ms": 4239.513874053955}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:24.938515", "span_type": "llm", "prompt_tokens": 334, "completion_tokens": 395, "model": "deepseek/deepseek-chat"}
{"span_id": "6e41f57a6de8118c", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "2595c0d7834130b8", "name": "sme.domain_insights", "kind": "INTERNAL", "start_time": 1755776120698127000, "end_time": 1755776124939914000, "duration_ns": 4241787000, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:24.939988"}
{"span_id": "03f9b1bb385a3839", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "d0dfa42932e5b074", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776124941004200, "end_time": 1755776131198708400, "duration_ns": 6257704200, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('\\n        As a pharmaceutical regulatory expert specializing in GAMP Category 4, assess the regulatory considerations for a validation project with these characteristics:\\n        \\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - GAMP Category: unknown\\n        - Validation Focus: enhanced\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        \\n        Assess regulatory considerations including:\\n        1. GAMP-5 category-specific requirements\\n        2. 21 CFR Part 11 electronic records compliance\\n        3. FDA Data Integrity Guidance (ALCOA+ principles)\\n        4. ICH guidelines applicable to the specialty\\n        5. EU GMP Annex 11 requirements\\n        6. Any specialty-specific regulatory requirements\\n        \\n        For each consideration, provide:\\n        - Specific regulation/guideline\\n        - Key consideration or requirement\\n        - Impact level (low/medium/high/critical)\\n        - Required actions\\n        - Implementation timeline phase\\n        \\n        Respond with valid JSON in this exact format:\\n        [\\n            {\\n                \"regulation\": \"regulation_name\",\\n                \"consideration\": \"specific_consideration_or_requirement\",\\n                \"impact\": \"low/medium/high/critical\",\\n                \"action_required\": \"specific_action_needed\",\\n                \"timeline\": \"design_phase/implementation_phase/validation_phase/ongoing\"\\n            }\\n        ]\\n        ',)", "input.value": "\n        As a pharmaceutical regulatory expert specializing in GAMP Category 4, assess the regulatory considerations for a validation project with these characteristics:\n        \n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - GAMP Category: unknown\n        - Validation Focus: enhanced\n        - Test Focus: OQ testing for pharmaceutical compliance\n        \n        Assess regulatory considerations including:\n        1. GAMP-5 category-specific requirements\n        2. 21 CFR Part 11 electronic records compliance\n        3. FDA Data Integrity Guidance (ALCOA+ principles)\n        4. ICH guidelines applicable to the specialty\n        5. EU GMP Annex 11 requirements\n        6. Any specialty-specific regulatory requirements\n        \n        For each consideration, provide:\n        - Specific regulation/guideline\n        - Key consideration or requirement\n        - Impact level (low/medium/high/critical)\n        - Required actions\n        - Implementation timeline phase\n        \n        Respond with valid JSON in this exact format:\n        [\n            {\n                \"regulation\": \"regulation_name\",\n                \"consideration\": \"specific_consideration_or_requirement\",\n                \"impact\": \"low/medium/high/critical\",\n                \"action_required\": \"specific_action_needed\",\n                \"timeline\": \"design_phase/implementation_phase/validation_phase/ongoing\"\n            }\n        ]\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "```json\n[\n    {\n        \"regulation\": \"GAMP-5\",\n        \"consideration\": \"Category 4 systems require a risk-based approach to validation, focusing on enhanced testing and documentation.\",\n        \"impact\": \"high\",\n        \"action_required\": \"Develop a risk assessment plan and validation strategy tailored to Category 4 requirements.\",\n        \"timeline\": \"design_phase\"\n    },\n    {\n        \"regulation\": \"21 CFR Part 11\",\n        \"consideration\": \"Ensure electronic records and signatures are secure, reliable, and traceable.\",\n        \"impact\": \"critical\",\n        \"action_required\": \"Implement controls for electronic records, including audit trails, access controls, and data integrity checks.\",\n        \"timeline\": \"implementation_phase\"\n    },\n    {\n        \"regulation\": \"FDA Data Integrity Guidance (ALCOA+)\",\n        \"consideration\": \"Ensure data is Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available.\",\n        \"impact\": \"critical\",\n        \"action_required\": \"Establish procedures to ensure compliance with ALCOA+ principles, including data review and audit trails.\",\n        \"timeline\": \"implementation_phase\"\n    },\n    {\n        \"regulation\": \"ICH Q7\",\n        \"consideration\": \"Ensure compliance with Good Manufacturing Practice (GMP) for active pharmaceutical ingredients.\",\n        \"impact\": \"high\",\n        \"action_required\": \"Align validation activities with ICH Q7 guidelines, focusing on GMP compliance.\",\n        \"timeline\": \"design_phase\"\n    },\n    {\n        \"regulation\": \"EU GMP Annex 11\",\n        \"consideration\": \"Ensure computerized systems are validated, secure, and maintain data integrity.\",\n        \"impact\": \"critical\",\n        \"action_required\": \"Implement Annex 11 requirements, including risk management, validation, and periodic review.\",\n        \"timeline\": \"validation_phase\"\n    },\n    {\n        \"regulation\": \"Specialty-specific requirements\",\n        \"consideration\": \"Ensure compliance with specific regulatory requirements for pharmaceutical systems, such as pharmacovigilance or serialization.\",\n        \"impact\": \"high\",\n        \"action_required\": \"Identify and address any specialty-specific regulatory requirements relevant to the system.\",\n        \"timeline\": \"design_phase\"\n    }\n]\n```", "llm.token_count.prompt": 363, "llm.token_count.completion": 573, "llm.token_count.total": 936, "llm.latency_ms": 6257.384538650513}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:31.198812", "span_type": "llm", "prompt_tokens": 363, "completion_tokens": 573, "model": "deepseek/deepseek-chat"}
{"span_id": "d0dfa42932e5b074", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "2595c0d7834130b8", "name": "sme.regulatory_considerations", "kind": "INTERNAL", "start_time": 1755776124940602600, "end_time": 1755776131199992700, "duration_ns": 6259390100, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:31.200025"}
{"span_id": "414d55ee0bf4d77f", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "d8081d0297d72e94", "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776131201034400, "end_time": 1755776136563579600, "duration_ns": 5362545200, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "(\"\\n        As a pharmaceutical validation expert specializing in GAMP Category 4, formulate a comprehensive expert opinion based on the complete analysis conducted:\\n        \\n        SYSTEM CONTEXT:\\n        - Specialty: GAMP Category 4\\n        - Compliance Level: high\\n        - Test Focus: OQ testing for pharmaceutical compliance\\n        - GAMP Category: unknown\\n        \\n        ANALYSIS RESULTS:\\n        Risk Analysis: {'identified_risks': [{'category': 'Regulatory Compliance', 'risk': 'Potential gaps in meeting high compliance requirements due to unknown GAMP category', 'probability': 'medium', 'impact': 'critical', 'mitigation': 'Conduct a detailed GAMP category assessment and align validation activities with regulatory expectations'}, {'category': 'Technical Complexity', 'risk': 'Integration risks due to system complexity and lack of defined risk factors', 'probability': 'high', 'impact': 'high', 'mitigation': 'Perform a thorough technical risk assessment and develop a robust integration testing plan'}, {'category': 'Data Integrity', 'risk': 'Potential non-compliance with ALCOA+ principles due to insufficient focus on data integrity', 'probability': 'medium', 'impact': 'critical', 'mitigation': 'Implement data integrity checks and validation protocols aligned with ALCOA+ principles'}, {'category': 'Validation Lifecycle', 'risk': 'Incomplete validation lifecycle due to enhanced focus without clear scope', 'probability': 'medium', 'impact': 'high', 'mitigation': 'Define a clear validation lifecycle scope and ensure all phases are adequately addressed'}, {'category': 'Change Control', 'risk': 'Inadequate change control processes leading to configuration management issues', 'probability': 'low', 'impact': 'medium', 'mitigation': 'Establish a robust change control process and ensure proper documentation of configuration changes'}], 'risk_level': 'high', 'mitigation_strategies': [{'strategy': 'Conduct a GAMP category assessment to clarify system classification', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Develop and execute a comprehensive technical risk assessment plan', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Implement data integrity protocols aligned with ALCOA+ principles', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Define and document the validation lifecycle scope', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Establish a robust change control process', 'priority': 'medium', 'timeline': 'future'}], 'critical_concerns': ['Unknown GAMP category leading to regulatory compliance gaps', 'Potential non-compliance with ALCOA+ principles'], 'clarity_score': 0.7}\\n        \\n        Recommendations Generated: 10 recommendations\\n        High Priority Recommendations: 3\\n        \\n        Formulate a concise expert opinion that:\\n        1. Summarizes the overall validation approach recommended\\n        2. Highlights key risk considerations and mitigation strategies\\n        3. Provides guidance on implementation priorities\\n        4. Addresses compliance and regulatory considerations\\n        5. Offers professional judgment on success likelihood\\n        \\n        Write in a professional, authoritative tone appropriate for pharmaceutical validation documentation.\\n        Keep the opinion concise but comprehensive (2-4 sentences).\\n        \\n        Respond with just the expert opinion text, no JSON formatting needed.\\n        \",)", "input.value": "\n        As a pharmaceutical validation expert specializing in GAMP Category 4, formulate a comprehensive expert opinion based on the complete analysis conducted:\n        \n        SYSTEM CONTEXT:\n        - Specialty: GAMP Category 4\n        - Compliance Level: high\n        - Test Focus: OQ testing for pharmaceutical compliance\n        - GAMP Category: unknown\n        \n        ANALYSIS RESULTS:\n        Risk Analysis: {'identified_risks': [{'category': 'Regulatory Compliance', 'risk': 'Potential gaps in meeting high compliance requirements due to unknown GAMP category', 'probability': 'medium', 'impact': 'critical', 'mitigation': 'Conduct a detailed GAMP category assessment and align validation activities with regulatory expectations'}, {'category': 'Technical Complexity', 'risk': 'Integration risks due to system complexity and lack of defined risk factors', 'probability': 'high', 'impact': 'high', 'mitigation': 'Perform a thorough technical risk assessment and develop a robust integration testing plan'}, {'category': 'Data Integrity', 'risk': 'Potential non-compliance with ALCOA+ principles due to insufficient focus on data integrity', 'probability': 'medium', 'impact': 'critical', 'mitigation': 'Implement data integrity checks and validation protocols aligned with ALCOA+ principles'}, {'category': 'Validation Lifecycle', 'risk': 'Incomplete validation lifecycle due to enhanced focus without clear scope', 'probability': 'medium', 'impact': 'high', 'mitigation': 'Define a clear validation lifecycle scope and ensure all phases are adequately addressed'}, {'category': 'Change Control', 'risk': 'Inadequate change control processes leading to configuration management issues', 'probability': 'low', 'impact': 'medium', 'mitigation': 'Establish a robust change control process and ensure proper documentation of configuration changes'}], 'risk_level': 'high', 'mitigation_strategies': [{'strategy': 'Conduct a GAMP category assessment to clarify system classification', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Develop and execute a comprehensive technical risk assessment plan', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Implement data integrity protocols aligned with ALCOA+ principles', 'priority': 'critical', 'timeline': 'immediate'}, {'strategy': 'Define and document the validation lifecycle scope', 'priority': 'high', 'timeline': 'planned'}, {'strategy': 'Establish a robust change control process', 'priority': 'medium', 'timeline': 'future'}], 'critical_concerns': ['Unknown GAMP category leading to regulatory compliance gaps', 'Potential non-compliance with ALCOA+ principles'], 'clarity_score': 0.7}\n        \n        Recommendations Generated: 10 recommendations\n        High Priority Recommendations: 3\n        \n        Formulate a concise expert opinion that:\n        1. Summarizes the overall validation approach recommended\n        2. Highlights key risk considerations and mitigation strategies\n        3. Provides guidance on implementation priorities\n        4. Addresses compliance and regulatory considerations\n        5. Offers professional judgment on success likelihood\n        \n        Write in a professional, authoritative tone appropriate for pharmaceutical validation documentation.\n        Keep the opinion concise but comprehensive (2-4 sentences).\n        \n        Respond with just the expert opinion text, no JSON formatting needed.\n        ", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 30000, \"provider\": \"openrouter\"}", "output.value": "The recommended validation approach emphasizes a structured, risk-based methodology, beginning with an immediate GAMP category assessment to clarify system classification and ensure alignment with regulatory expectations. Key risks, particularly in regulatory compliance and data integrity, must be mitigated through critical actions such as implementing ALCOA+ principles and conducting comprehensive technical risk assessments. Prioritize immediate execution of high-impact strategies, including defining the validation lifecycle scope and establishing robust change control processes, to address critical concerns and enhance compliance. With diligent implementation of these measures, the likelihood of achieving a successful, compliant validation outcome is high, provided all identified risks are systematically managed and documented.", "llm.token_count.prompt": 859, "llm.token_count.completion": 210, "llm.token_count.total": 1069, "llm.latency_ms": 5362.274408340454}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:36.563717", "span_type": "llm", "prompt_tokens": 859, "completion_tokens": 210, "model": "deepseek/deepseek-chat"}
{"span_id": "d8081d0297d72e94", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "2595c0d7834130b8", "name": "sme.expert_opinion", "kind": "INTERNAL", "start_time": 1755776131200389900, "end_time": 1755776136564504500, "duration_ns": 5364114600, "status": {"status_code": "UNSET", "description": null}, "attributes": {}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:36.564532"}
{"span_id": "2595c0d7834130b8", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": "853815e5d9873582", "name": "sme.execute", "kind": "INTERNAL", "start_time": 1755776094642879400, "end_time": 1755776136564838100, "duration_ns": 41921958700, "status": {"status_code": "UNSET", "description": null}, "attributes": {"sme.request_id": "350fa2ec-5ba0-4e27-8337-fd8f7a42d559", "sme.specialty": "GAMP Category 4", "sme.compliance_level": "high", "sme.compliance_status": "unknown", "sme.risk_level": "high", "sme.recommendations_count": 10, "sme.confidence_score": 0.5599999999999999, "sme.final_confidence": 0.5599999999999999, "sme.recommendations_final": 10}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:36.564866"}
{"span_id": "853815e5d9873582", "trace_id": "c2290138e6a1be22e6c1a8b04f3cbf8a", "parent_id": null, "name": "sme_agent.process_request", "kind": "INTERNAL", "start_time": 1755776094642718000, "end_time": 1755776136565425700, "duration_ns": 41922707700, "status": {"status_code": "UNSET", "description": null}, "attributes": {"agent.method": "process_request", "agent.module": "src.agents.parallel.sme_agent", "agent.type": "sme_agent", "operation": "process_request", "agent.class": "SMEAgent", "request.correlation_id": "350fa2ec-5ba0-4e27-8337-fd8f7a42d559", "request.specialty": "GAMP Category 4", "request.compliance_level": "high", "request.test_focus": "OQ testing for pharmaceutical compliance", "request.risk_factors": "{}", "request.timeout_seconds": 360, "compliance.gamp5.sme": true, "compliance.pharmaceutical": true, "sme.specialty": "GAMP Category 4", "result.recommendations_count": 10, "result.confidence_score": 0.5599999999999999, "result.risk_level": "high", "result.validation_points_count": 0, "result.processing_time_seconds": 41.92235, "result.success": true}, "events": [{"name": "sme_analysis_start", "timestamp": 1755776094642835000, "attributes": {"specialty": "GAMP Category 4", "compliance_level": "high", "test_focus": "OQ testing for pharmaceutical compliance"}}, {"name": "sme_analysis_complete", "timestamp": 1755776136565152000, "attributes": {"recommendations_count": 10, "confidence_score": 0.5599999999999999, "risk_level": "high", "processing_time": 41.92235}}], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:36.565472"}
{"span_id": "225c22cac2139149", "trace_id": "9e86c2a69cc747a7261eb9b0d4bffb46", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776136577917800, "end_time": 1755776145059474300, "duration_ns": 8481556500, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 1 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-022.md\\nURS CONTENT: # URS-022: Configured Deviation Management\\n**GAMP Category**: (Configured Product)\\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\\n**Domain**: Quality Assurance\\n**Complexity Level**: Medium-High\\n\\n## 1. Introduction\\nImplement a deviation management workflow using vendor\\'s configuration framework including state models, business rules, and reporting templates.\\n\\n## 2. Functional Requirements\\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\\n- URS-022-002: Implement risk scoring rules using vendor scripting.\\n- URS-022-003: Configure mandatory fields and attachments by risk level.\\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\\n- URS-022-005: Enforce e-signatures at key state transitions.\\n- URS-022-006: Implement SLA timers with escalation notifications.\\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\\n\\n## 3. Regulatory Requirements\\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\\n- URS-022-010: Retention and retrieval of closed records per policy.\\n\\n## 4. Performance Requirements\\n- URS-022-011: Handle 500 concurrent users across sites.\\n- URS-022-012: Search latency < 2 seconds for 1M records.\\n\\n## 5. Integration Requirements\\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\\n\\n\\n\\n\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-001 through OQ-002\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-001, OQ-002, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-001\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 1 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-022.md\nURS CONTENT: # URS-022: Configured Deviation Management\n**GAMP Category**: (Configured Product)\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\n**Domain**: Quality Assurance\n**Complexity Level**: Medium-High\n\n## 1. Introduction\nImplement a deviation management workflow using vendor's configuration framework including state models, business rules, and reporting templates.\n\n## 2. Functional Requirements\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\n- URS-022-002: Implement risk scoring rules using vendor scripting.\n- URS-022-003: Configure mandatory fields and attachments by risk level.\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\n- URS-022-005: Enforce e-signatures at key state transitions.\n- URS-022-006: Implement SLA timers with escalation notifications.\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\n\n## 3. Regulatory Requirements\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\n- URS-022-010: Retention and retrieval of closed records per policy.\n\n## 4. Performance Requirements\n- URS-022-011: Handle 500 concurrent users across sites.\n- URS-022-012: Search latency < 2 seconds for 1M records.\n\n## 5. Integration Requirements\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\n\n\n\n\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-001 through OQ-002\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-001, OQ-002, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-001\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-001\",\n            \"test_name\": \"Verify Deviation Lifecycle Configuration\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To verify that the deviation lifecycle is correctly configured with states: Draft, Under Review, Investigation, CAPA, and Closure.\",\n            \"prerequisites\": [\"System access credentials\", \"Configured deviation management workflow\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system and navigate to the deviation management module.\",\n                    \"expected_result\": \"User successfully logs in and accesses the deviation management module.\",\n                    \"data_to_capture\": [\"Login status\", \"Module access status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new deviation record and observe the initial state.\",\n                    \"expected_result\": \"New deviation record is created and initial state is set to Draft.\",\n                    \"data_to_capture\": [\"Record creation status\", \"Initial state\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Transition the deviation through each state: Under Review, Investigation, CAPA, and Closure.\",\n                    \"expected_result\": \"Deviation successfully transitions through each state as per configuration.\",\n                    \"data_to_capture\": [\"State transition status\", \"State sequence\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Deviation lifecycle states are correctly configured and transitions are successful.\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Ensure all state transitions are logged in the audit trail.\"],\n            \"urs_requirements\": [\"URS-022-001\"],\n            \"related_tests\": [\"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Quality Assurance\", \"System Configuration\"]\n        },\n        {\n            \"test_id\": \"OQ-002\",\n            \"test_name\": \"Validate Risk Scoring Rules Implementation\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To validate that risk scoring rules are correctly implemented using vendor scripting.\",\n            \"prerequisites\": [\"System access credentials\", \"Configured risk scoring rules\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system and navigate to the deviation management module.\",\n                    \"expected_result\": \"User successfully logs in and accesses the deviation management module.\",\n                    \"data_to_capture\": [\"Login status\", \"Module access status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new deviation record and input risk assessment data.\",\n                    \"expected_result\": \"New deviation record is created and risk assessment data is inputted.\",\n                    \"data_to_capture\": [\"Record creation status\", \"Risk assessment data\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Verify the calculated risk score based on the inputted data.\",\n                    \"expected_result\": \"Risk score is correctly calculated according to the configured rules.\",\n                    \"data_to_capture\": [\"Calculated risk score\", \"Risk scoring rules\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Risk scoring rules are correctly implemented and risk scores are accurately calculated.\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Ensure all risk scoring calculations are logged in the audit trail.\"],\n            \"urs_requirements\": [\"URS-022-002\"],\n            \"related_tests\": [\"OQ-001\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Quality Assurance\", \"System Configuration\"]\n        }\n    ]\n}", "llm.token_count.prompt": 802, "llm.token_count.completion": 1078, "llm.token_count.total": 1880, "llm.latency_ms": 8481.28890991211}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:35:45.059588", "span_type": "llm", "prompt_tokens": 802, "completion_tokens": 1078, "model": "deepseek/deepseek-chat"}
{"span_id": "84986a464b944bee", "trace_id": "7f5d906cd49e3ac2c21de1db4025965b", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776147067935500, "end_time": 1755776183862815300, "duration_ns": 36794879800, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 2 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-022.md\\nURS CONTENT: # URS-022: Configured Deviation Management\\n**GAMP Category**: (Configured Product)\\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\\n**Domain**: Quality Assurance\\n**Complexity Level**: Medium-High\\n\\n## 1. Introduction\\nImplement a deviation management workflow using vendor\\'s configuration framework including state models, business rules, and reporting templates.\\n\\n## 2. Functional Requirements\\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\\n- URS-022-002: Implement risk scoring rules using vendor scripting.\\n- URS-022-003: Configure mandatory fields and attachments by risk level.\\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\\n- URS-022-005: Enforce e-signatures at key state transitions.\\n- URS-022-006: Implement SLA timers with escalation notifications.\\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\\n\\n## 3. Regulatory Requirements\\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\\n- URS-022-010: Retention and retrieval of closed records per policy.\\n\\n## 4. Performance Requirements\\n- URS-022-011: Handle 500 concurrent users across sites.\\n- URS-022-012: Search latency < 2 seconds for 1M records.\\n\\n## 5. Integration Requirements\\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002\\n\\nTest IDs: OQ-003 through OQ-004 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-003 through OQ-004\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-003, OQ-004, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-003\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 2 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-022.md\nURS CONTENT: # URS-022: Configured Deviation Management\n**GAMP Category**: (Configured Product)\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\n**Domain**: Quality Assurance\n**Complexity Level**: Medium-High\n\n## 1. Introduction\nImplement a deviation management workflow using vendor's configuration framework including state models, business rules, and reporting templates.\n\n## 2. Functional Requirements\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\n- URS-022-002: Implement risk scoring rules using vendor scripting.\n- URS-022-003: Configure mandatory fields and attachments by risk level.\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\n- URS-022-005: Enforce e-signatures at key state transitions.\n- URS-022-006: Implement SLA timers with escalation notifications.\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\n\n## 3. Regulatory Requirements\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\n- URS-022-010: Retention and retrieval of closed records per policy.\n\n## 4. Performance Requirements\n- URS-022-011: Handle 500 concurrent users across sites.\n- URS-022-012: Search latency < 2 seconds for 1M records.\n\n## 5. Integration Requirements\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002\n\nTest IDs: OQ-003 through OQ-004 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-003 through OQ-004\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-003, OQ-004, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-003\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "```json\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-003\",\n            \"test_name\": \"Deviation Lifecycle State Transition Verification\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that the deviation lifecycle states (Draft, Under Review, Investigation, CAPA, Closure) transition correctly according to configured rules.\",\n            \"prerequisites\": [\n                \"System is configured with deviation workflow\",\n                \"Test user with appropriate permissions is available\"\n            ],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system and create a new deviation in Draft state.\",\n                    \"expected_result\": \"Deviation is successfully created and visible in Draft state.\",\n                    \"data_to_capture\": [\"Deviation ID\", \"Initial state\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Transition the deviation to Under Review state and verify required fields.\",\n                    \"expected_result\": \"Deviation transitions to Under Review state only when mandatory fields are completed.\",\n                    \"data_to_capture\": [\"Transition success/failure\", \"Missing fields (if any)\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Attempt to transition through all states up to Closure, capturing e-signature requirements.\",\n                    \"expected_result\": \"Each state transition enforces e-signatures where configured and follows business rules.\",\n                    \"data_to_capture\": [\"E-signature prompts\", \"Transition timestamps\"]\n                }\n            ],\n            \"acceptance_criteria\": [\n                \"All state transitions comply with configured workflow rules\",\n                \"E-signatures are enforced at specified transitions\",\n                \"Mandatory fields are validated before state changes\"\n            ],\n            \"regulatory_basis\": [\n                \"21 CFR Part 11 for e-signatures\",\n                \"ALCOA+ for audit trail requirements\"\n            ],\n            \"risk_level\": \"high\",\n            \"data_integrity_requirements\": [\n                \"Audit trail must capture all state transitions\",\n                \"Record must retain all e-signatures and timestamps\"\n            ],\n            \"urs_requirements\": [\n                \"URS-022-001 (Lifecycle states)\",\n                \"URS-022-005 (E-signatures)\",\n                \"URS-022-008 (Audit trail)\"\n            ],\n            \"related_tests\": [\"OQ-001 (System Access)\"],\n            \"estimated_duration_minutes\": 45,\n            \"required_expertise\": [\"QMS workflow configuration\", \"Regulatory compliance\"]\n        },\n        {\n            \"test_id\": \"OQ-004\",\n            \"test_name\": \"Risk-Based Field Enforcement Validation\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Validate that mandatory fields and attachments are enforced according to configured risk scoring rules.\",\n            \"prerequisites\": [\n                \"System with configured risk scoring rules\",\n                \"Test deviations with different risk levels\"\n            ],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a deviation with low risk score and attempt to submit without attachments.\",\n                    \"expected_result\": \"System allows submission when no attachments are required for low risk.\",\n                    \"data_to_capture\": [\"Risk score\", \"Attachment requirements\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a high-risk deviation missing required investigation fields.\",\n                    \"expected_result\": \"System prevents state transition until all mandatory high-risk fields are completed.\",\n                    \"data_to_capture\": [\"Missing fields\", \"Error messages\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Verify risk score recalculation after field updates.\",\n                    \"expected_result\": \"Changing risk-impacting fields automatically updates risk score and requirements.\",\n                    \"data_to_capture\": [\"Score before/after changes\", \"Field dependencies\"]\n                }\n            ],\n            \"acceptance_criteria\": [\n                \"Field enforcement matches configured risk rules\",\n                \"Risk score calculations are accurate and immediate\",\n                \"System prevents progression when requirements aren't met\"\n            ],\n            \"regulatory_basis\": [\n                \"ICH Q9 Quality Risk Management\",\n                \"21 CFR Part 11 for electronic records\"\n            ],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\n                \"Risk scores must be stored with deviation records\",\n                \"All field validations must be logged in audit trail\"\n            ],\n            \"urs_requirements\": [\n                \"URS-022-002 (Risk scoring)\",\n                \"URS-022-003 (Mandatory fields)\",\n                \"URS-022-008 (Audit trail)\"\n            ],\n            \"related_tests\": [\"OQ-003 (Lifecycle)\"],\n            \"estimated_duration_minutes\": 35,\n            \"required_expertise\": [\"Risk assessment methodologies\", \"System configuration\"]\n        }\n    ]\n}\n```", "llm.token_count.prompt": 827, "llm.token_count.completion": 1392, "llm.token_count.total": 2219, "llm.latency_ms": 36794.51107978821}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:36:23.862986", "span_type": "llm", "prompt_tokens": 827, "completion_tokens": 1392, "model": "deepseek/deepseek-chat"}
{"span_id": "3dc1c80f26849ccb", "trace_id": "934e8765d7913fcd68ec0900140ba157", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776185876589100, "end_time": 1755776224586798400, "duration_ns": 38710209300, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 3 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-022.md\\nURS CONTENT: # URS-022: Configured Deviation Management\\n**GAMP Category**: (Configured Product)\\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\\n**Domain**: Quality Assurance\\n**Complexity Level**: Medium-High\\n\\n## 1. Introduction\\nImplement a deviation management workflow using vendor\\'s configuration framework including state models, business rules, and reporting templates.\\n\\n## 2. Functional Requirements\\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\\n- URS-022-002: Implement risk scoring rules using vendor scripting.\\n- URS-022-003: Configure mandatory fields and attachments by risk level.\\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\\n- URS-022-005: Enforce e-signatures at key state transitions.\\n- URS-022-006: Implement SLA timers with escalation notifications.\\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\\n\\n## 3. Regulatory Requirements\\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\\n- URS-022-010: Retention and retrieval of closed records per policy.\\n\\n## 4. Performance Requirements\\n- URS-022-011: Handle 500 concurrent users across sites.\\n- URS-022-012: Search latency < 2 seconds for 1M records.\\n\\n## 5. Integration Requirements\\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004\\n\\nTest IDs: OQ-005 through OQ-006 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-005 through OQ-006\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-005, OQ-006, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-005\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 3 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-022.md\nURS CONTENT: # URS-022: Configured Deviation Management\n**GAMP Category**: (Configured Product)\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\n**Domain**: Quality Assurance\n**Complexity Level**: Medium-High\n\n## 1. Introduction\nImplement a deviation management workflow using vendor's configuration framework including state models, business rules, and reporting templates.\n\n## 2. Functional Requirements\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\n- URS-022-002: Implement risk scoring rules using vendor scripting.\n- URS-022-003: Configure mandatory fields and attachments by risk level.\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\n- URS-022-005: Enforce e-signatures at key state transitions.\n- URS-022-006: Implement SLA timers with escalation notifications.\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\n\n## 3. Regulatory Requirements\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\n- URS-022-010: Retention and retrieval of closed records per policy.\n\n## 4. Performance Requirements\n- URS-022-011: Handle 500 concurrent users across sites.\n- URS-022-012: Search latency < 2 seconds for 1M records.\n\n## 5. Integration Requirements\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004\n\nTest IDs: OQ-005 through OQ-006 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-005 through OQ-006\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-005, OQ-006, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-005\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "```json\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-005\",\n            \"test_name\": \"Deviation Lifecycle State Transition Verification\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that the configured deviation lifecycle states (Draft, Under Review, Investigation, CAPA, Closure) transition correctly according to business rules.\",\n            \"prerequisites\": [\n                \"System configured with deviation workflow\",\n                \"Test user with appropriate permissions\",\n                \"Sample deviation record in Draft state\"\n            ],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in as a QA user and open the deviation record in Draft state.\",\n                    \"expected_result\": \"Deviation record is displayed with Draft status and editable fields.\",\n                    \"data_to_capture\": [\"Current state of deviation\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Submit the deviation for review and verify state transition.\",\n                    \"expected_result\": \"State changes to Under Review and appropriate notifications are sent.\",\n                    \"data_to_capture\": [\"New state of deviation\", \"Notification log\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Approve the deviation and initiate investigation.\",\n                    \"expected_result\": \"State changes to Investigation and investigation team is assigned.\",\n                    \"data_to_capture\": [\"New state of deviation\", \"Assigned team\"]\n                }\n            ],\n            \"acceptance_criteria\": [\n                \"All state transitions occur as configured\",\n                \"Required fields are enforced at each state\",\n                \"E-signatures are captured at designated transitions\"\n            ],\n            \"regulatory_basis\": [\n                \"21 CFR Part 11\",\n                \"EU Annex 11\"\n            ],\n            \"risk_level\": \"high\",\n            \"data_integrity_requirements\": [\n                \"ALCOA+ compliant audit trail for all state changes\",\n                \"E-signature verification at critical transitions\"\n            ],\n            \"urs_requirements\": [\n                \"URS-022-001\",\n                \"URS-022-005\"\n            ],\n            \"related_tests\": [\"OQ-001\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\n                \"Quality Assurance\",\n                \"System Configuration\"\n            ]\n        },\n        {\n            \"test_id\": \"OQ-006\",\n            \"test_name\": \"Risk-Based Field Enforcement Validation\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Validate that mandatory fields and attachments are properly enforced based on configured risk scoring rules.\",\n            \"prerequisites\": [\n                \"System configured with risk scoring rules\",\n                \"Test users with deviation creation permissions\",\n                \"Sample high-risk and low-risk deviation scenarios\"\n            ],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a new deviation with low risk score and attempt to submit without all mandatory fields.\",\n                    \"expected_result\": \"System prevents submission and highlights missing mandatory fields.\",\n                    \"data_to_capture\": [\"Error messages\", \"Highlighted fields\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Complete all mandatory fields for low risk deviation and submit.\",\n                    \"expected_result\": \"Deviation is successfully submitted with only basic required fields.\",\n                    \"data_to_capture\": [\"Submitted deviation record\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Create a high-risk deviation and verify additional mandatory fields and attachments.\",\n                    \"expected_result\": \"System enforces additional requirements for high-risk deviations.\",\n                    \"data_to_capture\": [\"Required fields list\", \"Attachment requirements\"]\n                }\n            ],\n            \"acceptance_criteria\": [\n                \"Field enforcement matches configured rules for each risk level\",\n                \"System prevents progression when requirements are not met\",\n                \"Risk score calculation is accurate per configured algorithm\"\n            ],\n            \"regulatory_basis\": [\n                \"ICH Q9\",\n                \"21 CFR Part 11\"\n            ],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\n                \"Risk score calculation audit trail\",\n                \"Field requirement enforcement logs\"\n            ],\n            \"urs_requirements\": [\n                \"URS-022-002\",\n                \"URS-022-003\"\n            ],\n            \"related_tests\": [\"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\n                \"Risk Management\",\n                \"Quality Systems\"\n            ]\n        }\n    ]\n}\n```", "llm.token_count.prompt": 831, "llm.token_count.completion": 1337, "llm.token_count.total": 2168, "llm.latency_ms": 38709.948778152466}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:37:04.586895", "span_type": "llm", "prompt_tokens": 831, "completion_tokens": 1337, "model": "deepseek/deepseek-chat"}
{"span_id": "c5b591e8e892a2a3", "trace_id": "3ecb7c329f0135d73990ceceef29d16d", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776226593452200, "end_time": 1755776259366387400, "duration_ns": 32772935200, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 4 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-022.md\\nURS CONTENT: # URS-022: Configured Deviation Management\\n**GAMP Category**: (Configured Product)\\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\\n**Domain**: Quality Assurance\\n**Complexity Level**: Medium-High\\n\\n## 1. Introduction\\nImplement a deviation management workflow using vendor\\'s configuration framework including state models, business rules, and reporting templates.\\n\\n## 2. Functional Requirements\\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\\n- URS-022-002: Implement risk scoring rules using vendor scripting.\\n- URS-022-003: Configure mandatory fields and attachments by risk level.\\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\\n- URS-022-005: Enforce e-signatures at key state transitions.\\n- URS-022-006: Implement SLA timers with escalation notifications.\\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\\n\\n## 3. Regulatory Requirements\\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\\n- URS-022-010: Retention and retrieval of closed records per policy.\\n\\n## 4. Performance Requirements\\n- URS-022-011: Handle 500 concurrent users across sites.\\n- URS-022-012: Search latency < 2 seconds for 1M records.\\n\\n## 5. Integration Requirements\\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006\\n\\nTest IDs: OQ-007 through OQ-008 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-007 through OQ-008\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-007, OQ-008, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-007\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 4 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-022.md\nURS CONTENT: # URS-022: Configured Deviation Management\n**GAMP Category**: (Configured Product)\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\n**Domain**: Quality Assurance\n**Complexity Level**: Medium-High\n\n## 1. Introduction\nImplement a deviation management workflow using vendor's configuration framework including state models, business rules, and reporting templates.\n\n## 2. Functional Requirements\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\n- URS-022-002: Implement risk scoring rules using vendor scripting.\n- URS-022-003: Configure mandatory fields and attachments by risk level.\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\n- URS-022-005: Enforce e-signatures at key state transitions.\n- URS-022-006: Implement SLA timers with escalation notifications.\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\n\n## 3. Regulatory Requirements\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\n- URS-022-010: Retention and retrieval of closed records per policy.\n\n## 4. Performance Requirements\n- URS-022-011: Handle 500 concurrent users across sites.\n- URS-022-012: Search latency < 2 seconds for 1M records.\n\n## 5. Integration Requirements\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006\n\nTest IDs: OQ-007 through OQ-008 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-007 through OQ-008\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-007, OQ-008, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-007\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-007\",\n            \"test_name\": \"Verify Deviation Lifecycle State Transitions\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Ensure the deviation lifecycle states (Draft, Under Review, Investigation, CAPA, Closure) transition correctly based on configured rules.\",\n            \"prerequisites\": [\"System configured with deviation lifecycle states\", \"Test user with appropriate permissions\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a new deviation record in the Draft state.\",\n                    \"expected_result\": \"Deviation record is successfully created in the Draft state.\",\n                    \"data_to_capture\": [\"Deviation ID\", \"Current State\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Transition the deviation to the Under Review state.\",\n                    \"expected_result\": \"Deviation record transitions to the Under Review state.\",\n                    \"data_to_capture\": [\"Transition Time\", \"User Performing Transition\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Transition the deviation to the Investigation state.\",\n                    \"expected_result\": \"Deviation record transitions to the Investigation state.\",\n                    \"data_to_capture\": [\"Transition Time\", \"User Performing Transition\"]\n                },\n                {\n                    \"step_number\": 4,\n                    \"action\": \"Transition the deviation to the CAPA state.\",\n                    \"expected_result\": \"Deviation record transitions to the CAPA state.\",\n                    \"data_to_capture\": [\"Transition Time\", \"User Performing Transition\"]\n                },\n                {\n                    \"step_number\": 5,\n                    \"action\": \"Transition the deviation to the Closure state.\",\n                    \"expected_result\": \"Deviation record transitions to the Closure state.\",\n                    \"data_to_capture\": [\"Transition Time\", \"User Performing Transition\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"All state transitions occur as expected\", \"Audit trail records each transition\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\", \"ALCOA+\"],\n            \"risk_level\": \"high\",\n            \"data_integrity_requirements\": [\"Audit trail must capture all state transitions\", \"Mandatory fields must be populated at each state\"],\n            \"urs_requirements\": [\"URS-022-001\", \"URS-022-005\"],\n            \"related_tests\": [\"OQ-001\", \"OQ-003\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"QMS Workflow Configuration\", \"Deviation Management\"]\n        },\n        {\n            \"test_id\": \"OQ-008\",\n            \"test_name\": \"Validate CAPA Linkage and Effectiveness Checks\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that CAPA records are correctly linked to deviations and effectiveness checks are enforced.\",\n            \"prerequisites\": [\"System configured with CAPA workflow\", \"Test deviation record in CAPA state\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a CAPA record linked to the deviation.\",\n                    \"expected_result\": \"CAPA record is successfully created and linked to the deviation.\",\n                    \"data_to_capture\": [\"CAPA ID\", \"Linked Deviation ID\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Perform an effectiveness check on the CAPA record.\",\n                    \"expected_result\": \"Effectiveness check is completed and recorded in the CAPA record.\",\n                    \"data_to_capture\": [\"Effectiveness Check Date\", \"User Performing Check\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Verify the CAPA record status after effectiveness check.\",\n                    \"expected_result\": \"CAPA record status reflects the outcome of the effectiveness check.\",\n                    \"data_to_capture\": [\"CAPA Status\", \"Effectiveness Check Result\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"CAPA records are correctly linked to deviations\", \"Effectiveness checks are enforced and recorded\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\", \"ALCOA+\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Audit trail must capture CAPA linkage and effectiveness checks\", \"Mandatory fields must be populated for CAPA records\"],\n            \"urs_requirements\": [\"URS-022-007\"],\n            \"related_tests\": [\"OQ-002\", \"OQ-004\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"CAPA Management\", \"QMS Workflow Configuration\"]\n        }\n    ]\n}", "llm.token_count.prompt": 835, "llm.token_count.completion": 1261, "llm.token_count.total": 2096, "llm.latency_ms": 32772.44305610657}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:37:39.366596", "span_type": "llm", "prompt_tokens": 835, "completion_tokens": 1261, "model": "deepseek/deepseek-chat"}
{"span_id": "3296d791739920c4", "trace_id": "abd468be5c3ef001dcd48a79f8cc773a", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776261383960900, "end_time": 1755776272268789500, "duration_ns": 10884828600, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 5 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-022.md\\nURS CONTENT: # URS-022: Configured Deviation Management\\n**GAMP Category**: (Configured Product)\\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\\n**Domain**: Quality Assurance\\n**Complexity Level**: Medium-High\\n\\n## 1. Introduction\\nImplement a deviation management workflow using vendor\\'s configuration framework including state models, business rules, and reporting templates.\\n\\n## 2. Functional Requirements\\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\\n- URS-022-002: Implement risk scoring rules using vendor scripting.\\n- URS-022-003: Configure mandatory fields and attachments by risk level.\\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\\n- URS-022-005: Enforce e-signatures at key state transitions.\\n- URS-022-006: Implement SLA timers with escalation notifications.\\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\\n\\n## 3. Regulatory Requirements\\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\\n- URS-022-010: Retention and retrieval of closed records per policy.\\n\\n## 4. Performance Requirements\\n- URS-022-011: Handle 500 concurrent users across sites.\\n- URS-022-012: Search latency < 2 seconds for 1M records.\\n\\n## 5. Integration Requirements\\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008\\n\\nTest IDs: OQ-009 through OQ-010 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-009 through OQ-010\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-009, OQ-010, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-009\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 5 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-022.md\nURS CONTENT: # URS-022: Configured Deviation Management\n**GAMP Category**: (Configured Product)\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\n**Domain**: Quality Assurance\n**Complexity Level**: Medium-High\n\n## 1. Introduction\nImplement a deviation management workflow using vendor's configuration framework including state models, business rules, and reporting templates.\n\n## 2. Functional Requirements\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\n- URS-022-002: Implement risk scoring rules using vendor scripting.\n- URS-022-003: Configure mandatory fields and attachments by risk level.\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\n- URS-022-005: Enforce e-signatures at key state transitions.\n- URS-022-006: Implement SLA timers with escalation notifications.\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\n\n## 3. Regulatory Requirements\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\n- URS-022-010: Retention and retrieval of closed records per policy.\n\n## 4. Performance Requirements\n- URS-022-011: Handle 500 concurrent users across sites.\n- URS-022-012: Search latency < 2 seconds for 1M records.\n\n## 5. Integration Requirements\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008\n\nTest IDs: OQ-009 through OQ-010 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-009 through OQ-010\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-009, OQ-010, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-009\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-009\",\n            \"test_name\": \"Verify Deviation Lifecycle Configuration\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To ensure the deviation lifecycle is correctly configured with states: Draft, Under Review, Investigation, CAPA, Closure.\",\n            \"prerequisites\": [\"Access to the QMS system\", \"Configured deviation management workflow\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Navigate to the deviation management module.\",\n                    \"expected_result\": \"Deviation management module is accessible.\",\n                    \"data_to_capture\": [\"Module accessibility\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new deviation record.\",\n                    \"expected_result\": \"Deviation record is created with Draft state.\",\n                    \"data_to_capture\": [\"Record creation status\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Transition the deviation through all configured states.\",\n                    \"expected_result\": \"Deviation transitions correctly through all states.\",\n                    \"data_to_capture\": [\"State transition status\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Deviation lifecycle states are correctly configured and functional.\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Ensure all state transitions are logged in the audit trail.\"],\n            \"urs_requirements\": [\"URS-022-001\"],\n            \"related_tests\": [\"OQ-001\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"QMS configuration\", \"Deviation management\"]\n        },\n        {\n            \"test_id\": \"OQ-010\",\n            \"test_name\": \"Validate Risk Scoring Rules Implementation\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To verify the implementation of risk scoring rules using vendor scripting.\",\n            \"prerequisites\": [\"Access to the QMS system\", \"Configured risk scoring rules\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Navigate to the risk scoring configuration section.\",\n                    \"expected_result\": \"Risk scoring configuration section is accessible.\",\n                    \"data_to_capture\": [\"Section accessibility\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new deviation record with varying risk factors.\",\n                    \"expected_result\": \"Risk score is calculated correctly based on configured rules.\",\n                    \"data_to_capture\": [\"Risk score calculation\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Verify the risk score updates with changes to risk factors.\",\n                    \"expected_result\": \"Risk score updates dynamically with changes.\",\n                    \"data_to_capture\": [\"Dynamic risk score updates\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Risk scoring rules are correctly implemented and functional.\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"high\",\n            \"data_integrity_requirements\": [\"Ensure risk score calculations are logged in the audit trail.\"],\n            \"urs_requirements\": [\"URS-022-002\"],\n            \"related_tests\": [\"OQ-002\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Risk management\", \"Scripting\"]\n        }\n    ]\n}", "llm.token_count.prompt": 839, "llm.token_count.completion": 968, "llm.token_count.total": 1807, "llm.latency_ms": 10884.461641311646}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:37:52.268894", "span_type": "llm", "prompt_tokens": 839, "completion_tokens": 968, "model": "deepseek/deepseek-chat"}
{"span_id": "e57272d4b152d9c8", "trace_id": "1181069ef20f07436729e2aacf7805c6", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776274276098600, "end_time": 1755776287537051500, "duration_ns": 13260952900, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 6 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-022.md\\nURS CONTENT: # URS-022: Configured Deviation Management\\n**GAMP Category**: (Configured Product)\\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\\n**Domain**: Quality Assurance\\n**Complexity Level**: Medium-High\\n\\n## 1. Introduction\\nImplement a deviation management workflow using vendor\\'s configuration framework including state models, business rules, and reporting templates.\\n\\n## 2. Functional Requirements\\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\\n- URS-022-002: Implement risk scoring rules using vendor scripting.\\n- URS-022-003: Configure mandatory fields and attachments by risk level.\\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\\n- URS-022-005: Enforce e-signatures at key state transitions.\\n- URS-022-006: Implement SLA timers with escalation notifications.\\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\\n\\n## 3. Regulatory Requirements\\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\\n- URS-022-010: Retention and retrieval of closed records per policy.\\n\\n## 4. Performance Requirements\\n- URS-022-011: Handle 500 concurrent users across sites.\\n- URS-022-012: Search latency < 2 seconds for 1M records.\\n\\n## 5. Integration Requirements\\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010\\n\\nTest IDs: OQ-011 through OQ-012 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-011 through OQ-012\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-011, OQ-012, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-011\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 6 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-022.md\nURS CONTENT: # URS-022: Configured Deviation Management\n**GAMP Category**: (Configured Product)\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\n**Domain**: Quality Assurance\n**Complexity Level**: Medium-High\n\n## 1. Introduction\nImplement a deviation management workflow using vendor's configuration framework including state models, business rules, and reporting templates.\n\n## 2. Functional Requirements\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\n- URS-022-002: Implement risk scoring rules using vendor scripting.\n- URS-022-003: Configure mandatory fields and attachments by risk level.\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\n- URS-022-005: Enforce e-signatures at key state transitions.\n- URS-022-006: Implement SLA timers with escalation notifications.\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\n\n## 3. Regulatory Requirements\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\n- URS-022-010: Retention and retrieval of closed records per policy.\n\n## 4. Performance Requirements\n- URS-022-011: Handle 500 concurrent users across sites.\n- URS-022-012: Search latency < 2 seconds for 1M records.\n\n## 5. Integration Requirements\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010\n\nTest IDs: OQ-011 through OQ-012 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-011 through OQ-012\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-011, OQ-012, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-011\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-011\",\n            \"test_name\": \"Verify Deviation Lifecycle State Transitions\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Ensure the deviation lifecycle states (Draft, Under Review, Investigation, CAPA, Closure) are correctly configured and enforced.\",\n            \"prerequisites\": [\"System configured with deviation lifecycle states\", \"Test user with appropriate permissions\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a new deviation record and set the state to Draft.\",\n                    \"expected_result\": \"Deviation record is created and state is set to Draft.\",\n                    \"data_to_capture\": [\"Deviation ID\", \"State\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Transition the deviation state to Under Review.\",\n                    \"expected_result\": \"State is updated to Under Review and e-signature is enforced.\",\n                    \"data_to_capture\": [\"State\", \"E-signature\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Transition the deviation state to Investigation.\",\n                    \"expected_result\": \"State is updated to Investigation and mandatory fields are enforced.\",\n                    \"data_to_capture\": [\"State\", \"Mandatory Fields\"]\n                },\n                {\n                    \"step_number\": 4,\n                    \"action\": \"Transition the deviation state to CAPA.\",\n                    \"expected_result\": \"State is updated to CAPA and CAPA linkage is enforced.\",\n                    \"data_to_capture\": [\"State\", \"CAPA Linkage\"]\n                },\n                {\n                    \"step_number\": 5,\n                    \"action\": \"Transition the deviation state to Closure.\",\n                    \"expected_result\": \"State is updated to Closure and record is closed.\",\n                    \"data_to_capture\": [\"State\", \"Closure Date\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"All state transitions are correctly enforced\", \"E-signatures are enforced at key transitions\", \"Mandatory fields are enforced by risk level\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\", \"ALCOA+\"],\n            \"risk_level\": \"high\",\n            \"data_integrity_requirements\": [\"Audit trail for state transitions\", \"Record integrity during state changes\"],\n            \"urs_requirements\": [\"URS-022-001\", \"URS-022-005\"],\n            \"related_tests\": [\"OQ-012\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"QMS Configuration\", \"Deviation Management\"]\n        },\n        {\n            \"test_id\": \"OQ-012\",\n            \"test_name\": \"Validate Risk Scoring Rules and Mandatory Fields\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that risk scoring rules are correctly implemented and mandatory fields are enforced based on risk level.\",\n            \"prerequisites\": [\"System configured with risk scoring rules\", \"Test user with appropriate permissions\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a new deviation record and assign a low risk score.\",\n                    \"expected_result\": \"Deviation record is created with low risk score.\",\n                    \"data_to_capture\": [\"Deviation ID\", \"Risk Score\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Verify mandatory fields and attachments for low risk.\",\n                    \"expected_result\": \"Mandatory fields and attachments are correctly enforced for low risk.\",\n                    \"data_to_capture\": [\"Mandatory Fields\", \"Attachments\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Assign a high risk score to the deviation record.\",\n                    \"expected_result\": \"Risk score is updated to high.\",\n                    \"data_to_capture\": [\"Risk Score\"]\n                },\n                {\n                    \"step_number\": 4,\n                    \"action\": \"Verify mandatory fields and attachments for high risk.\",\n                    \"expected_result\": \"Mandatory fields and attachments are correctly enforced for high risk.\",\n                    \"data_to_capture\": [\"Mandatory Fields\", \"Attachments\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Risk scoring rules are correctly implemented\", \"Mandatory fields and attachments are enforced based on risk level\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\", \"ALCOA+\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Audit trail for risk score changes\", \"Record integrity during risk score updates\"],\n            \"urs_requirements\": [\"URS-022-002\", \"URS-022-003\"],\n            \"related_tests\": [\"OQ-011\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"QMS Configuration\", \"Risk Management\"]\n        }\n    ]\n}", "llm.token_count.prompt": 843, "llm.token_count.completion": 1304, "llm.token_count.total": 2147, "llm.latency_ms": 13260.606288909912}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:38:07.537170", "span_type": "llm", "prompt_tokens": 843, "completion_tokens": 1304, "model": "deepseek/deepseek-chat"}
{"span_id": "edba8f1d23219735", "trace_id": "140395b60e580294babde76df60c0f8c", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776289543520300, "end_time": 1755776301025144800, "duration_ns": 11481624500, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 7 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-022.md\\nURS CONTENT: # URS-022: Configured Deviation Management\\n**GAMP Category**: (Configured Product)\\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\\n**Domain**: Quality Assurance\\n**Complexity Level**: Medium-High\\n\\n## 1. Introduction\\nImplement a deviation management workflow using vendor\\'s configuration framework including state models, business rules, and reporting templates.\\n\\n## 2. Functional Requirements\\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\\n- URS-022-002: Implement risk scoring rules using vendor scripting.\\n- URS-022-003: Configure mandatory fields and attachments by risk level.\\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\\n- URS-022-005: Enforce e-signatures at key state transitions.\\n- URS-022-006: Implement SLA timers with escalation notifications.\\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\\n\\n## 3. Regulatory Requirements\\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\\n- URS-022-010: Retention and retrieval of closed records per policy.\\n\\n## 4. Performance Requirements\\n- URS-022-011: Handle 500 concurrent users across sites.\\n- URS-022-012: Search latency < 2 seconds for 1M records.\\n\\n## 5. Integration Requirements\\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012\\n\\nTest IDs: OQ-013 through OQ-014 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-013 through OQ-014\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-013, OQ-014, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-013\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 7 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-022.md\nURS CONTENT: # URS-022: Configured Deviation Management\n**GAMP Category**: (Configured Product)\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\n**Domain**: Quality Assurance\n**Complexity Level**: Medium-High\n\n## 1. Introduction\nImplement a deviation management workflow using vendor's configuration framework including state models, business rules, and reporting templates.\n\n## 2. Functional Requirements\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\n- URS-022-002: Implement risk scoring rules using vendor scripting.\n- URS-022-003: Configure mandatory fields and attachments by risk level.\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\n- URS-022-005: Enforce e-signatures at key state transitions.\n- URS-022-006: Implement SLA timers with escalation notifications.\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\n\n## 3. Regulatory Requirements\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\n- URS-022-010: Retention and retrieval of closed records per policy.\n\n## 4. Performance Requirements\n- URS-022-011: Handle 500 concurrent users across sites.\n- URS-022-012: Search latency < 2 seconds for 1M records.\n\n## 5. Integration Requirements\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012\n\nTest IDs: OQ-013 through OQ-014 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-013 through OQ-014\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-013, OQ-014, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-013\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-013\",\n            \"test_name\": \"Verify Deviation Lifecycle State Transitions\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Ensure the deviation lifecycle states (Draft, Under Review, Investigation, CAPA, Closure) are correctly configured and transitions are enforced with e-signatures.\",\n            \"prerequisites\": [\"System configured with deviation lifecycle states\", \"User access granted\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a new deviation record and set it to Draft state.\",\n                    \"expected_result\": \"Deviation record is created and set to Draft state.\",\n                    \"data_to_capture\": [\"Deviation ID\", \"State\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Transition the deviation record to Under Review state.\",\n                    \"expected_result\": \"Deviation record transitions to Under Review state with e-signature prompt.\",\n                    \"data_to_capture\": [\"State\", \"E-signature\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Transition the deviation record to Investigation state.\",\n                    \"expected_result\": \"Deviation record transitions to Investigation state with e-signature prompt.\",\n                    \"data_to_capture\": [\"State\", \"E-signature\"]\n                },\n                {\n                    \"step_number\": 4,\n                    \"action\": \"Transition the deviation record to CAPA state.\",\n                    \"expected_result\": \"Deviation record transitions to CAPA state with e-signature prompt.\",\n                    \"data_to_capture\": [\"State\", \"E-signature\"]\n                },\n                {\n                    \"step_number\": 5,\n                    \"action\": \"Transition the deviation record to Closure state.\",\n                    \"expected_result\": \"Deviation record transitions to Closure state with e-signature prompt.\",\n                    \"data_to_capture\": [\"State\", \"E-signature\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"All state transitions are correctly enforced with e-signatures.\", \"Deviation lifecycle states are correctly configured.\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"high\",\n            \"data_integrity_requirements\": [\"ALCOA+ compliant audit trail\"],\n            \"urs_requirements\": [\"URS-022-001\", \"URS-022-005\"],\n            \"related_tests\": [\"OQ-014\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"QMS Configuration\", \"Deviation Management\"]\n        },\n        {\n            \"test_id\": \"OQ-014\",\n            \"test_name\": \"Validate Risk Scoring Rules and Mandatory Fields\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that risk scoring rules are correctly implemented and mandatory fields and attachments are enforced based on risk level.\",\n            \"prerequisites\": [\"System configured with risk scoring rules\", \"User access granted\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a new deviation record with low risk level.\",\n                    \"expected_result\": \"Deviation record is created with low risk level.\",\n                    \"data_to_capture\": [\"Deviation ID\", \"Risk Level\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Attempt to save the deviation record without filling mandatory fields.\",\n                    \"expected_result\": \"System prevents saving and prompts to fill mandatory fields.\",\n                    \"data_to_capture\": [\"Error Message\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Create a new deviation record with high risk level.\",\n                    \"expected_result\": \"Deviation record is created with high risk level.\",\n                    \"data_to_capture\": [\"Deviation ID\", \"Risk Level\"]\n                },\n                {\n                    \"step_number\": 4,\n                    \"action\": \"Attempt to save the deviation record without attaching required documents.\",\n                    \"expected_result\": \"System prevents saving and prompts to attach required documents.\",\n                    \"data_to_capture\": [\"Error Message\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Risk scoring rules are correctly implemented.\", \"Mandatory fields and attachments are enforced based on risk level.\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"ALCOA+ compliant audit trail\"],\n            \"urs_requirements\": [\"URS-022-002\", \"URS-022-003\"],\n            \"related_tests\": [\"OQ-013\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"QMS Configuration\", \"Risk Management\"]\n        }\n    ]\n}", "llm.token_count.prompt": 847, "llm.token_count.completion": 1295, "llm.token_count.total": 2142, "llm.latency_ms": 11481.279373168945}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:38:21.025306", "span_type": "llm", "prompt_tokens": 847, "completion_tokens": 1295, "model": "deepseek/deepseek-chat"}
{"span_id": "13dabc4532328f07", "trace_id": "c5c35028992926ec5da779d0b440c6d3", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776303041953700, "end_time": 1755776313733286400, "duration_ns": 10691332700, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 8 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-022.md\\nURS CONTENT: # URS-022: Configured Deviation Management\\n**GAMP Category**: (Configured Product)\\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\\n**Domain**: Quality Assurance\\n**Complexity Level**: Medium-High\\n\\n## 1. Introduction\\nImplement a deviation management workflow using vendor\\'s configuration framework including state models, business rules, and reporting templates.\\n\\n## 2. Functional Requirements\\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\\n- URS-022-002: Implement risk scoring rules using vendor scripting.\\n- URS-022-003: Configure mandatory fields and attachments by risk level.\\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\\n- URS-022-005: Enforce e-signatures at key state transitions.\\n- URS-022-006: Implement SLA timers with escalation notifications.\\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\\n\\n## 3. Regulatory Requirements\\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\\n- URS-022-010: Retention and retrieval of closed records per policy.\\n\\n## 4. Performance Requirements\\n- URS-022-011: Handle 500 concurrent users across sites.\\n- URS-022-012: Search latency < 2 seconds for 1M records.\\n\\n## 5. Integration Requirements\\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014\\n\\nTest IDs: OQ-015 through OQ-016 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-015 through OQ-016\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-015, OQ-016, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-015\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 8 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-022.md\nURS CONTENT: # URS-022: Configured Deviation Management\n**GAMP Category**: (Configured Product)\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\n**Domain**: Quality Assurance\n**Complexity Level**: Medium-High\n\n## 1. Introduction\nImplement a deviation management workflow using vendor's configuration framework including state models, business rules, and reporting templates.\n\n## 2. Functional Requirements\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\n- URS-022-002: Implement risk scoring rules using vendor scripting.\n- URS-022-003: Configure mandatory fields and attachments by risk level.\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\n- URS-022-005: Enforce e-signatures at key state transitions.\n- URS-022-006: Implement SLA timers with escalation notifications.\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\n\n## 3. Regulatory Requirements\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\n- URS-022-010: Retention and retrieval of closed records per policy.\n\n## 4. Performance Requirements\n- URS-022-011: Handle 500 concurrent users across sites.\n- URS-022-012: Search latency < 2 seconds for 1M records.\n\n## 5. Integration Requirements\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014\n\nTest IDs: OQ-015 through OQ-016 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-015 through OQ-016\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-015, OQ-016, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-015\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-015\",\n            \"test_name\": \"Verify Deviation Lifecycle Configuration\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To verify that the deviation lifecycle is correctly configured with the states: Draft, Under Review, Investigation, CAPA, and Closure.\",\n            \"prerequisites\": [\"System access credentials\", \"Configured deviation management workflow\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system and navigate to the deviation management module.\",\n                    \"expected_result\": \"User successfully logs in and accesses the deviation management module.\",\n                    \"data_to_capture\": [\"Login status\", \"Module access status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new deviation record and observe the initial state.\",\n                    \"expected_result\": \"New deviation record is created and is in the Draft state.\",\n                    \"data_to_capture\": [\"Record creation status\", \"Initial state\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Transition the deviation record through each state: Under Review, Investigation, CAPA, and Closure.\",\n                    \"expected_result\": \"Deviation record successfully transitions through each state.\",\n                    \"data_to_capture\": [\"State transition status\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Deviation lifecycle states are correctly configured and transitions are successful.\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"ALCOA+ compliant audit trail\"],\n            \"urs_requirements\": [\"URS-022-001\"],\n            \"related_tests\": [\"OQ-016\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Quality Assurance\", \"System Configuration\"]\n        },\n        {\n            \"test_id\": \"OQ-016\",\n            \"test_name\": \"Validate Risk Scoring Rules Implementation\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To validate that the risk scoring rules are correctly implemented using vendor scripting.\",\n            \"prerequisites\": [\"System access credentials\", \"Configured risk scoring rules\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the system and navigate to the deviation management module.\",\n                    \"expected_result\": \"User successfully logs in and accesses the deviation management module.\",\n                    \"data_to_capture\": [\"Login status\", \"Module access status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new deviation record and input risk factors.\",\n                    \"expected_result\": \"New deviation record is created with risk factors input.\",\n                    \"data_to_capture\": [\"Record creation status\", \"Risk factors input\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Verify the calculated risk score based on the input risk factors.\",\n                    \"expected_result\": \"Risk score is correctly calculated according to the configured rules.\",\n                    \"data_to_capture\": [\"Calculated risk score\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Risk scoring rules are correctly implemented and risk scores are accurately calculated.\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"ALCOA+ compliant audit trail\"],\n            \"urs_requirements\": [\"URS-022-002\"],\n            \"related_tests\": [\"OQ-015\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"Quality Assurance\", \"System Configuration\"]\n        }\n    ]\n}", "llm.token_count.prompt": 851, "llm.token_count.completion": 1044, "llm.token_count.total": 1895, "llm.latency_ms": 10690.885782241821}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:38:33.733562", "span_type": "llm", "prompt_tokens": 851, "completion_tokens": 1044, "model": "deepseek/deepseek-chat"}
{"span_id": "87b802c824d931c2", "trace_id": "a4427b8462fd0cbb412effa6e5cb764d", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776315742036100, "end_time": 1755776326226980600, "duration_ns": 10484944500, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 9 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-022.md\\nURS CONTENT: # URS-022: Configured Deviation Management\\n**GAMP Category**: (Configured Product)\\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\\n**Domain**: Quality Assurance\\n**Complexity Level**: Medium-High\\n\\n## 1. Introduction\\nImplement a deviation management workflow using vendor\\'s configuration framework including state models, business rules, and reporting templates.\\n\\n## 2. Functional Requirements\\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\\n- URS-022-002: Implement risk scoring rules using vendor scripting.\\n- URS-022-003: Configure mandatory fields and attachments by risk level.\\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\\n- URS-022-005: Enforce e-signatures at key state transitions.\\n- URS-022-006: Implement SLA timers with escalation notifications.\\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\\n\\n## 3. Regulatory Requirements\\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\\n- URS-022-010: Retention and retrieval of closed records per policy.\\n\\n## 4. Performance Requirements\\n- URS-022-011: Handle 500 concurrent users across sites.\\n- URS-022-012: Search latency < 2 seconds for 1M records.\\n\\n## 5. Integration Requirements\\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014, OQ-015, OQ-016\\n\\nTest IDs: OQ-017 through OQ-018 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-017 through OQ-018\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-017, OQ-018, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-017\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 9 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-022.md\nURS CONTENT: # URS-022: Configured Deviation Management\n**GAMP Category**: (Configured Product)\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\n**Domain**: Quality Assurance\n**Complexity Level**: Medium-High\n\n## 1. Introduction\nImplement a deviation management workflow using vendor's configuration framework including state models, business rules, and reporting templates.\n\n## 2. Functional Requirements\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\n- URS-022-002: Implement risk scoring rules using vendor scripting.\n- URS-022-003: Configure mandatory fields and attachments by risk level.\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\n- URS-022-005: Enforce e-signatures at key state transitions.\n- URS-022-006: Implement SLA timers with escalation notifications.\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\n\n## 3. Regulatory Requirements\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\n- URS-022-010: Retention and retrieval of closed records per policy.\n\n## 4. Performance Requirements\n- URS-022-011: Handle 500 concurrent users across sites.\n- URS-022-012: Search latency < 2 seconds for 1M records.\n\n## 5. Integration Requirements\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014, OQ-015, OQ-016\n\nTest IDs: OQ-017 through OQ-018 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-017 through OQ-018\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-017, OQ-018, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-017\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-017\",\n            \"test_name\": \"Verify Deviation Lifecycle Configuration\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To verify that the deviation lifecycle is correctly configured with states: Draft, Under Review, Investigation, CAPA, Closure.\",\n            \"prerequisites\": [\"Access to the QMS system\", \"Test deviation record\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the QMS system and navigate to the deviation management module.\",\n                    \"expected_result\": \"User is able to access the deviation management module.\",\n                    \"data_to_capture\": [\"Login status\", \"Module access\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new deviation record and save it as Draft.\",\n                    \"expected_result\": \"Deviation record is successfully saved in Draft state.\",\n                    \"data_to_capture\": [\"Record creation status\", \"State\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Transition the deviation record to Under Review state.\",\n                    \"expected_result\": \"Deviation record transitions to Under Review state successfully.\",\n                    \"data_to_capture\": [\"Transition status\", \"State\"]\n                },\n                {\n                    \"step_number\": 4,\n                    \"action\": \"Transition the deviation record to Investigation state.\",\n                    \"expected_result\": \"Deviation record transitions to Investigation state successfully.\",\n                    \"data_to_capture\": [\"Transition status\", \"State\"]\n                },\n                {\n                    \"step_number\": 5,\n                    \"action\": \"Transition the deviation record to CAPA state.\",\n                    \"expected_result\": \"Deviation record transitions to CAPA state successfully.\",\n                    \"data_to_capture\": [\"Transition status\", \"State\"]\n                },\n                {\n                    \"step_number\": 6,\n                    \"action\": \"Transition the deviation record to Closure state.\",\n                    \"expected_result\": \"Deviation record transitions to Closure state successfully.\",\n                    \"data_to_capture\": [\"Transition status\", \"State\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"All states are correctly configured and transitions are successful.\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Ensure all state transitions are logged in the audit trail.\"],\n            \"urs_requirements\": [\"URS-022-001\"],\n            \"related_tests\": [\"OQ-018\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"QMS system knowledge\", \"Deviation management\"]\n        },\n        {\n            \"test_id\": \"OQ-018\",\n            \"test_name\": \"Verify Risk Scoring Rules Implementation\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"To verify that risk scoring rules are correctly implemented using vendor scripting.\",\n            \"prerequisites\": [\"Access to the QMS system\", \"Test deviation record\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in to the QMS system and navigate to the deviation management module.\",\n                    \"expected_result\": \"User is able to access the deviation management module.\",\n                    \"data_to_capture\": [\"Login status\", \"Module access\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Create a new deviation record and input risk factors.\",\n                    \"expected_result\": \"Risk factors are accepted and risk score is calculated.\",\n                    \"data_to_capture\": [\"Risk factors\", \"Risk score\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Verify the calculated risk score against predefined rules.\",\n                    \"expected_result\": \"Risk score matches the expected value based on the rules.\",\n                    \"data_to_capture\": [\"Risk score\", \"Expected value\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"Risk scoring rules are correctly implemented and risk scores are accurate.\"],\n            \"regulatory_basis\": [\"21 CFR Part 11\"],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\"Ensure risk scores are logged in the audit trail.\"],\n            \"urs_requirements\": [\"URS-022-002\"],\n            \"related_tests\": [\"OQ-017\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"QMS system knowledge\", \"Risk management\"]\n        }\n    ]\n}", "llm.token_count.prompt": 855, "llm.token_count.completion": 1256, "llm.token_count.total": 2111, "llm.latency_ms": 10484.676837921143}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:38:46.227088", "span_type": "llm", "prompt_tokens": 855, "completion_tokens": 1256, "model": "deepseek/deepseek-chat"}
{"span_id": "1d4e7d19c46c4e88", "trace_id": "879e3a04b226e8f157d5adb88caa86aa", "parent_id": null, "name": "llm.completion", "kind": "INTERNAL", "start_time": 1755776328239928200, "end_time": 1755776376144127000, "duration_ns": 47904198800, "status": {"status_code": "OK", "description": null}, "attributes": {"llm.model_name": "deepseek/deepseek-chat", "llm.provider": "openrouter", "llm.system": "OpenRouter", "llm.prompts": "('You are generating BATCH 10 of 10 for a GAMP Category 4 OQ test suite.\\n\\nDOCUMENT: URS-022.md\\nURS CONTENT: # URS-022: Configured Deviation Management\\n**GAMP Category**: (Configured Product)\\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\\n**Domain**: Quality Assurance\\n**Complexity Level**: Medium-High\\n\\n## 1. Introduction\\nImplement a deviation management workflow using vendor\\'s configuration framework including state models, business rules, and reporting templates.\\n\\n## 2. Functional Requirements\\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\\n- URS-022-002: Implement risk scoring rules using vendor scripting.\\n- URS-022-003: Configure mandatory fields and attachments by risk level.\\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\\n- URS-022-005: Enforce e-signatures at key state transitions.\\n- URS-022-006: Implement SLA timers with escalation notifications.\\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\\n\\n## 3. Regulatory Requirements\\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\\n- URS-022-010: Retention and retrieval of closed records per policy.\\n\\n## 4. Performance Requirements\\n- URS-022-011: Handle 500 concurrent users across sites.\\n- URS-022-012: Search latency < 2 seconds for 1M records.\\n\\n## 5. Integration Requirements\\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\\n\\n\\n\\n\\n\\nPREVIOUS BATCH TESTS GENERATED:\\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014, OQ-015, OQ-016, OQ-017, OQ-018\\n\\nTest IDs: OQ-019 through OQ-020 (no duplicates).\\n\\n\\nBatch Requirements:\\n- Generate 2 tests for this batch\\n- Test IDs: OQ-019 through OQ-020\\n- Unique tests with comprehensive coverage\\n- Include all required fields\\n\\nDeepSeek V3 Instructions:\\nGenerate JSON matching OQTestSuite schema.\\n- Sequential test IDs: OQ-019, OQ-020, etc.\\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \\n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\\n\\nReturn only JSON starting with { and ending with }\\n\\nEXACT JSON Schema for this batch:\\n{\\n    \"test_cases\": [\\n        {\\n            \"test_id\": \"OQ-019\",\\n            \"test_name\": \"string (10-100 chars)\",\\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\\n            \"gamp_category\": 4,\\n            \"objective\": \"string (min 20 chars)\",\\n            \"prerequisites\": [\"string\"],\\n            \"test_steps\": [\\n                {\\n                    \"step_number\": 1,\\n                    \"action\": \"string (min 10 chars)\",\\n                    \"expected_result\": \"string (min 10 chars)\",\\n                    \"data_to_capture\": [\"string\"]\\n                }\\n            ],\\n            \"acceptance_criteria\": [\"string\"],\\n            \"regulatory_basis\": [\"string\"],\\n            \"risk_level\": \"low|medium|high|critical\",\\n            \"data_integrity_requirements\": [\"string\"],\\n            \"urs_requirements\": [\"string\"],\\n            \"related_tests\": [\"string\"],\\n            \"estimated_duration_minutes\": 30,\\n            \"required_expertise\": [\"string\"]\\n        }\\n        // ... repeat for 2 tests total\\n    ]\\n}',)", "input.value": "You are generating BATCH 10 of 10 for a GAMP Category 4 OQ test suite.\n\nDOCUMENT: URS-022.md\nURS CONTENT: # URS-022: Configured Deviation Management\n**GAMP Category**: (Configured Product)\n**System Type**: QMS deviation and CAPA workflows configured via vendor tools\n**Domain**: Quality Assurance\n**Complexity Level**: Medium-High\n\n## 1. Introduction\nImplement a deviation management workflow using vendor's configuration framework including state models, business rules, and reporting templates.\n\n## 2. Functional Requirements\n- URS-022-001: Configure deviation lifecycle with states: Draft, Under Review, Investigation, CAPA, Closure.\n- URS-022-002: Implement risk scoring rules using vendor scripting.\n- URS-022-003: Configure mandatory fields and attachments by risk level.\n- URS-022-004: Provide configured dashboards and standard reporting engine outputs.\n- URS-022-005: Enforce e-signatures at key state transitions.\n- URS-022-006: Implement SLA timers with escalation notifications.\n- URS-022-007: Provide CAPA linkage with effectiveness checks.\n\n## 3. Regulatory Requirements\n- URS-022-008: Full ALCOA+ compliant audit trail for record changes.\n- URS-022-009: 21 CFR Part 11 compliant e-signatures and access controls.\n- URS-022-010: Retention and retrieval of closed records per policy.\n\n## 4. Performance Requirements\n- URS-022-011: Handle 500 concurrent users across sites.\n- URS-022-012: Search latency < 2 seconds for 1M records.\n\n## 5. Integration Requirements\n- URS-022-013: Integrate with LDAP/AD and HRMS for user provisioning.\n- URS-022-014: API-based integration to send CAPA tasks to ticketing system.\n\n\n\n\n\nPREVIOUS BATCH TESTS GENERATED:\nOQ-001, OQ-002, OQ-003, OQ-004, OQ-005, OQ-006, OQ-007, OQ-008, OQ-009, OQ-010, OQ-011, OQ-012, OQ-013, OQ-014, OQ-015, OQ-016, OQ-017, OQ-018\n\nTest IDs: OQ-019 through OQ-020 (no duplicates).\n\n\nBatch Requirements:\n- Generate 2 tests for this batch\n- Test IDs: OQ-019 through OQ-020\n- Unique tests with comprehensive coverage\n- Include all required fields\n\nDeepSeek V3 Instructions:\nGenerate JSON matching OQTestSuite schema.\n- Sequential test IDs: OQ-019, OQ-020, etc.\n- risk_level: \"low\", \"medium\", \"high\", or \"critical\" \n- test_category: \"installation\", \"functional\", \"performance\", \"security\", \"data_integrity\", \"integration\"\n\nReturn only JSON starting with { and ending with }\n\nEXACT JSON Schema for this batch:\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-019\",\n            \"test_name\": \"string (10-100 chars)\",\n            \"test_category\": \"installation|functional|performance|security|data_integrity|integration\",\n            \"gamp_category\": 4,\n            \"objective\": \"string (min 20 chars)\",\n            \"prerequisites\": [\"string\"],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"string (min 10 chars)\",\n                    \"expected_result\": \"string (min 10 chars)\",\n                    \"data_to_capture\": [\"string\"]\n                }\n            ],\n            \"acceptance_criteria\": [\"string\"],\n            \"regulatory_basis\": [\"string\"],\n            \"risk_level\": \"low|medium|high|critical\",\n            \"data_integrity_requirements\": [\"string\"],\n            \"urs_requirements\": [\"string\"],\n            \"related_tests\": [\"string\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\"string\"]\n        }\n        // ... repeat for 2 tests total\n    ]\n}", "llm.invocation_parameters": "{\"model\": \"deepseek/deepseek-chat\", \"temperature\": 0.1, \"max_tokens\": 4000, \"provider\": \"openrouter\"}", "output.value": "```json\n{\n    \"test_cases\": [\n        {\n            \"test_id\": \"OQ-019\",\n            \"test_name\": \"Deviation Lifecycle State Transition Verification\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that the deviation lifecycle states (Draft, Under Review, Investigation, CAPA, Closure) transition correctly according to configured business rules.\",\n            \"prerequisites\": [\n                \"System configured with deviation workflow\",\n                \"Test user with appropriate permissions\",\n                \"Sample deviation record in Draft state\"\n            ],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Log in as a QA user and navigate to the deviation management module.\",\n                    \"expected_result\": \"User successfully accesses the deviation management interface.\",\n                    \"data_to_capture\": [\"Login success status\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Select the sample deviation record in Draft state and initiate transition to Under Review.\",\n                    \"expected_result\": \"System prompts for required fields and attachments before allowing transition.\",\n                    \"data_to_capture\": [\"Transition validation behavior\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Complete all mandatory fields and attach required documents, then submit for review.\",\n                    \"expected_result\": \"Deviation record successfully transitions to Under Review state with timestamp.\",\n                    \"data_to_capture\": [\"State transition success\", \"Audit trail entry\"]\n                },\n                {\n                    \"step_number\": 4,\n                    \"action\": \"Repeat transitions through all configured states (Investigation, CAPA, Closure) with appropriate approvals.\",\n                    \"expected_result\": \"Each state transition completes successfully with required e-signatures and audit trail entries.\",\n                    \"data_to_capture\": [\"State transition sequence\", \"Approval records\"]\n                }\n            ],\n            \"acceptance_criteria\": [\n                \"All state transitions execute according to configured workflow\",\n                \"Mandatory field validation enforced at each transition\",\n                \"E-signatures captured for all approval steps\",\n                \"Complete audit trail maintained for all state changes\"\n            ],\n            \"regulatory_basis\": [\n                \"21 CFR Part 11 electronic records requirements\",\n                \"ALCOA+ data integrity principles\"\n            ],\n            \"risk_level\": \"high\",\n            \"data_integrity_requirements\": [\n                \"State transitions must be recorded with timestamp and user ID\",\n                \"No state transitions should bypass required approvals\"\n            ],\n            \"urs_requirements\": [\n                \"URS-022-001: Configure deviation lifecycle states\",\n                \"URS-022-005: Enforce e-signatures at key transitions\",\n                \"URS-022-008: Full ALCOA+ audit trail\"\n            ],\n            \"related_tests\": [\"OQ-001\", \"OQ-005\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\n                \"Quality system workflow knowledge\",\n                \"Vendor configuration tools experience\"\n            ]\n        },\n        {\n            \"test_id\": \"OQ-020\",\n            \"test_name\": \"Risk-Based Field Configuration Validation\",\n            \"test_category\": \"functional\",\n            \"gamp_category\": 4,\n            \"objective\": \"Verify that mandatory fields and attachments are dynamically enforced based on configured risk scoring rules.\",\n            \"prerequisites\": [\n                \"System with configured risk scoring rules\",\n                \"Test deviations with different risk levels\",\n                \"Sample documents for attachment\"\n            ],\n            \"test_steps\": [\n                {\n                    \"step_number\": 1,\n                    \"action\": \"Create a new deviation record and set risk score to low (1-3).\",\n                    \"expected_result\": \"System displays only baseline mandatory fields for low-risk deviations.\",\n                    \"data_to_capture\": [\"Field display configuration\"]\n                },\n                {\n                    \"step_number\": 2,\n                    \"action\": \"Attempt to submit the deviation without completing all mandatory fields.\",\n                    \"expected_result\": \"System prevents submission and highlights missing fields.\",\n                    \"data_to_capture\": [\"Validation behavior\"]\n                },\n                {\n                    \"step_number\": 3,\n                    \"action\": \"Complete all mandatory fields and attach required documents, then submit.\",\n                    \"expected_result\": \"Deviation successfully submits with all required data.\",\n                    \"data_to_capture\": [\"Submission success status\"]\n                },\n                {\n                    \"step_number\": 4,\n                    \"action\": \"Repeat process with medium (4-6) and high (7-10) risk deviations.\",\n                    \"expected_result\": \"Additional fields and attachments become mandatory as risk level increases.\",\n                    \"data_to_capture\": [\"Dynamic field configuration\"]\n                }\n            ],\n            \"acceptance_criteria\": [\n                \"Field requirements match configured rules for each risk level\",\n                \"System prevents submission when required fields/attachments are missing\",\n                \"Risk score changes dynamically update field requirements\",\n                \"Configuration changes are reflected immediately without system restart\"\n            ],\n            \"regulatory_basis\": [\n                \"ICH Q9 Quality Risk Management\",\n                \"21 CFR Part 11 electronic records requirements\"\n            ],\n            \"risk_level\": \"medium\",\n            \"data_integrity_requirements\": [\n                \"Risk score must be captured before field validation\",\n                \"No bypass of mandatory field requirements\"\n            ],\n            \"urs_requirements\": [\n                \"URS-022-002: Implement risk scoring rules\",\n                \"URS-022-003: Configure mandatory fields by risk level\",\n                \"URS-022-008: Full ALCOA+ audit trail\"\n            ],\n            \"related_tests\": [\"OQ-002\", \"OQ-006\"],\n            \"estimated_duration_minutes\": 30,\n            \"required_expertise\": [\n                \"Risk assessment methodology\",\n                \"System configuration knowledge\"\n            ]\n        }\n    ]\n}\n```", "llm.token_count.prompt": 859, "llm.token_count.completion": 1702, "llm.token_count.total": 2561, "llm.latency_ms": 47903.92088890076}, "events": [], "links": [], "resource": {}, "pharmaceutical_system": true, "exporter": "LocalFileSpanExporter", "capture_time": "2025-08-21T12:39:36.144257", "span_type": "llm", "prompt_tokens": 859, "completion_tokens": 1702, "model": "deepseek/deepseek-chat"}
